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ABSTRACT 
 
 
Bioaugmentation has become an increasingly popular remediation strategy for 
groundwater sites contaminated with chlorinated solvents.  When biostimulation is not an 
option due to the lack of necessary microorganisms required for dechlorination of the 
contaminants, bioaugmentation is an attractive option for remediation.  The P-Area 
groundwater plumes at the Savannah River Site (SRS) are just such a case.  The P-Area 
site is contaminated with tetrachloroethene (PCE), trichloroethene (TCE), and cis-
dichloroethene (cDCE), and no dechlorination past cDCE is occurring.  A similar site, the 
C-Area site, is near one of the P-Area site’s source zones but displays complete reduction 
of TCE to ethene.  An enrichment culture was developed from the C-Area wetland for 
possible use as an indigenous bioaugmentation culture for the P-Area site.  The culture 
underwent characterization in terms of potential terminal electron acceptors, 
pathogenicity, susceptibility to 1,1,1-trichloroethane (1,1,1-TCA), potential use of 
emulsified vegetable oil as an electron donor, and response to oxygen exposure and a 
range of pH levels. 
The ability of the SRS culture, which was enriched on PCE and TCE, to use other 
halogenated alkenes and alkanes as terminal electron acceptors was investigated.  The 
SRS culture is capable of utilizing PCE, TCE, cDCE, trans-dichloroethene, 1,1-
dichloroethene, vinyl chloride (VC), 1,2-dichloroethane, 1,2-dibromoethane, and vinyl 
bromide as electron acceptors.  Additionally, the culture’s ability to dechlorinate several 
chlorinated benzenes was investigated.  The SRS culture can dechlorinate 
hexachlorobenzene, pentachlorobenzene, 1,2,4,5-tetrachlorobenzene, and 1,2,4-
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trichlorobenzene; however, further testing is required to determine if these electron 
acceptors are used metabolically as with the halogenated alkenes and alkanes.  The 
culture cannot dechlorinate the dichlorobenzene isomers or chlorobenzene. 
The SRS culture was tested for potential pathogenicity, which would hinder its 
regulatory approval as a bioaugmentation culture.  Initially, the culture’s ability to grow 
on a rich substrate (trypticase soy broth) at the temperature of the human body was tested.  
The culture grew aerobically at 37ºC, and further analysis using commercial coliform and 
E. coli testing kits revealed that the SRS culture does contain coliforms.  However, E. 
coli is not present in the culture.  Further molecular testing is being conducted at the 
Savannah River National Laboratory (SRNL) to determine if other pathogenic species 
might be present in the culture. 
As 1,1,1-TCA has been shown to be inhibitory to many dechlorinating cultures, 
the SRS culture’s susceptibility to this known inhibitor was evaluated.  The culture’s 
ability to completely dechlorinate TCE to ethene was inhibited by 300 µM 1,1,1-TCA; a 
mixture of VC and ethene were produced as end products.  Lower concentrations of 
1,1,1-TCA (0.7 and 3.6 µM) did not inhibit TCE conversion to ethene.  Additionally, the 
SRS culture was not capable of dechlorinating 1,1,1-TCA. 
The SRS culture was enriched on lactate as an electron donor, however, the use of 
emulsified oil substrate (EOS®) as an electron donor was investigated as it is a longer 
lasting electron donor.  A microcosm evaluation suggested that EOS® is a better electron 
donor than lactate.  Reductive dechlorination of PCE and TCE occurred faster and with 
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less accumulation of daughter products in treatments amended with EOS® than in those 
amended with lactate. 
The SRS culture was tested for its vulnerability to oxygen exposure, as it is an 
anaerobic culture, and exposure to oxygen could be detrimental to the success of the 
culture in the field.  Quiescent exposure to air (21% oxygen in headspace) for 24 hours 
slowed the dechlorination of PCE and TCE.  However, the culture was able to overcome 
the aerobic conditions and completely dechlorinate PCE and TCE to ethene.  The low 
redox conditions provided by the media in which the culture is maintained allowed for 
anaerobic conditions in the bottles to be reestablished.  Given low redox conditions in 
contaminated groundwater, the SRS culture should be able to sustain brief oxygen 
exposure and retain its reductive dechlorinating ability. 
Related to oxygen exposure, the SRS culture’s susceptibility to extreme pH levels 
was investigated.  The SRS culture is maintained in buffered minimal media within the 
pH range of 6.5-7.5.  The culture was exposed to a range of pH levels (5.5, 6.0, 6.5, 7.0, 
and 8.5) as well as a treatment in which pH was allowed to decrease from neutral, as a 
result of HCl release.  At pH 6.0, the dechlorinating activity of the SRS culture was 
slowed, and cDCE and VC accumulation was higher than at pH 7.0.  At pH 5.5, reductive 
dechlorination stopped at cDCE, with no production of VC or ethene.  When the pH was 
allowed to decrease from neutral, the culture exhibited a decrease in ethene production 
and accumulation of VC as the pH dropped below 6.0.  The culture was most strongly 
inhibited at pH 8.5; some PCE was dechlorinated, but no TCE was consumed.  Little to 
no cDCE or VC was produced.  Given these results, it will be necessary for groundwater 
 v 
pH to be adequately buffered at a pH of 6.5 or higher for successful bioaugmentation 
with the SRS culture. 
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CHAPTER ONE 
INTRODUCTION 
 
 Chlorinated ethenes are among the most common groundwater contaminants 
found at industrial sites throughout the United States.  The Department of Energy’s 
Savannah River Site (SRS) located in Aiken, South Carolina, is no exception.  The P-
Area plume is one of many chlorinated ethene plumes found at SRS.  Little is known 
about the P-Area plumes, and currently, work is being done to characterize these plumes.  
Field data have shown this site to be contaminated with tetrachloroethene (PCE), 
trichloroethene (TCE), and cis-dichloroethene (cDCE).  Maps of the PCE and TCE 
plumes are provided in Appendix A.  P-Area groundwater discharges to Steel Creek 
where TCE levels above the current maximum contaminant level set by the United States 
Environmental Protection Agency have been detected (42, 47).  There are two separate 
source zones for the P-Area plumes:  the P-Area Burning/Rubble Pit (PBRP) and the P-
Area Reactor. 
 The PBRP was built in 1951 to serve as a burning pit for organic chemicals, waste 
oils, wood, paper, plastics, and rubber.  In 1973, burning was terminated and the pit was 
covered with soil.  From 1973 until it reached its capacity in 1978, the pit was used to 
dispose of rubble such as brick, tile, concrete, asphalt, rubber, non returnable empty 
drums, and waste solvents including chlorinated ethenes (42).  After reaching capacity 
the pit and debris were covered with soil and no other actions were taken to remediate 
this site.  As a direct result of these past disposal practices, chlorinated ethenes 
contaminated both the soil and groundwater beneath the PBRP (47). 
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 The second area contributing to the P-Area plumes is the P-Area Reactor operable 
unit.  In this area, both TCE and PCE have been detected at levels as high as 21,100 ppb 
and 365 ppb, respectively.  These compounds have been detected in groundwater at a 
depth of approximately 15.2 m.  While the exact source of the contamination is unknown, 
it is believed that a dense non-aqueous phase liquid source is located near the reactor 
facility (46). 
 A similar site at SRS, the C-Area Burning/Rubble Pit, is close to the P-area 
Burning/Rubble Pit and displays complete reduction of TCE to ethene.  This plume 
extends approximately 1220 meters to the west and outcrops in the seepline along Twin 
Lakes and Fourmile Branch (42).  Another branch of the plume extends to the south and 
outcrops at Castor Creek (48).  In collaboration with SRNL, the Department of 
Environmental Engineering and Earth Sciences at Clemson University conducted a 
microcosm study using samples from the Twin Lakes seepline in the C-Area to confirm 
the occurrence of reductive dechlorination.  Dehalococcoides were detected in the sites 
closest to the wetland, but the product signal was especially weak and not considered 
definitive.  None of the sediment samples yielded signature terminal restriction fragments 
corresponding exactly to in silico digest predictions from 16S rRNA genes of 
Dehalococcoides ethenogenes strain 195 or other Dehalococcoides-like sequences (7).  
However, samples from the microcosms that actively dechlorinated cDCE and vinyl 
chloride (VC) to ethene and ethane exhibited strong positive signals for Dehalococcoides 
compared to the field samples.  Restriction digest analysis indicated strong genotypic 
similarity between Bachman Dehalococcoides 16S rRNA gene sequence and those from 
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the microcosms prepared with sediment closest to the wetland.  Perhaps most 
significantly, variant genotypes were also recovered, suggesting the presence of novel 
strains of Dehalococcoides (7). 
 Since the PCE plume in the PBRP is not attenuating naturally beyond cDCE, an 
active form of in situ remediation is necessary.  Both biostimulation (i.e., addition of 
electron donor) and bioaugmentation (i.e., addition of microorganisms plus electron 
donor) are possible remediation options.  Bioaugmentation has proven to be effective at 
many sites contaminated with chlorinated ethenes.  For example, a pilot scale study 
completed at Dover Air Force Base, Delaware involved a TCE-contaminated site where 
dechlorination was stalled at cDCE.  An enrichment culture known to dechlorinate both 
TCE and cDCE to ethene was used in bioaugmentation, and complete reduction to ethene 
was observed (15).  Another study was done at Kelly Air Force Base, Texas.  This site 
faced the problem of incomplete dechlorination from PCE to cDCE.  A different mixed 
culture was used and again there was complete reduction of PCE to ethene (34). 
 In many situations bioaugmentation has been the most attractive method of 
enhancing in situ dechlorination, especially in sites that are currently seeing a buildup in 
daughter products other than ethene.  A comparison of biostimulation versus 
bioaugmentation was done at another site contaminated with PCE.  This comparison 
showed that bioaugmentation was not only more extensive but complete reduction 
occurred in less than half the time of biostimulation (29).  Other studies have offered the 
same conclusion (9, 15, 34). 
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 The use of a site-developed bioaugmentation culture for SRS has its advantages.  
There will likely be a financial advantage in using the site-developed culture as opposed 
to a commercially available culture.  In addition, the likelihood of obtaining regulatory 
approval for using an indigenously derived culture is higher than when using an 
“imported” commercial culture.  Lastly, since the site where the microorganisms were 
initially discovered and the site that is being investigated for application are similar in 
geochemistry, the culture may also be better suited to survive in the PBRP. 
 To investigate the effectiveness of a site-developed culture in bioaugmenting the 
P-Area, Wood (45) developed a sediment-free enrichment culture from the C-Area 
microcosms.  A microcosm study using samples from the P-Area was then conducted to 
evaluate the effectiveness of biostimulation with several electron donors and 
bioaugmentation with the SRS enrichment culture.  The results confirmed that 
dechlorination activity in the bioaugmentation microcosms was significantly higher than 
that in the biostimulation microcosms.  Successful use of the SRS enrichment culture in 
bioaugmentation of the P-Area microcosms suggests that the SRS enrichment culture 
may be a feasible option for bioaugmenting the P-Area chlorinated ethene plume.  Given 
the promising results of the bioaugmentation microcosm study using the SRS enrichment 
culture, the main objectives of the research for this thesis were to scale up the enrichment 
culture for a field trial in the P-Area groundwater and to further characterize the culture 
as it relates to other chlorinated ethene bioaugmentation cultures.   
 The main focus of culture characterization was determining the range of terminal 
electron acceptors that the SRS culture is capable of using.  Various halogenated alkenes, 
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alkanes, and chlorinated benzenes were tested as potential terminal electron acceptors 
(TEAs).  Other known groups of Dehalococcoides (Cornell, Pinellas, and Victoria) 
respire a variety of halogenated compounds.  However, only Dehalococcoides 
ethenogenes strain 195 is known to halorespire chlorinated ethenes and halogenated 
ethanes as well as chlorinated benzenes.  For example, BAV1, VS, and KB-1TM can 
dechlorinate several of the chlorinated ethenes to ethene (12, 25, 35, 37), while CDBD1 
is able to chlororespire chlorinated benzenes but not PCE (8).  To quantitatively compare 
other Dehalococcoides-containing cultures and the SRS culture, growth yields were 
calculated for each TEA tested and compared to yields reported in literature (11). 
 Investigation of the pathogenicity of the enrichment culture was included in the 
scope of this thesis, due to health and safety concerns that accompany injection of a 
microbial culture into a groundwater supply.  Pathogenicity data on bioaugmentation 
cultures is limited, but Burkholderia cepacia (used for aerobic cometabolism of TCE) has 
been identified as an opportunistic human pathogen and EPA has imposed regulations on 
its use (16).  Other cultures, including Methylosinus trichosporium OB3b, KB-1TM, and 
mixed cultures from Bioremediation Consulting, Inc. have been reported as being 
nonpathogenic (16). 
 Other bioaugmentation cultures have been shown to be inhibited by the presence 
of low concentrations of 1,1,1-trichloroethane (1,1,1-TCA) and chloroform, which are 
common co-contaminants with chlorinated ethenes at many hazardous waste sites.  
Therefore, to be thorough in the comparison, susceptibility of the SRS culture to 1,1,1-
TCA was included in the culture characterization.  Grostern and Edwards (23) 
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documented inhibitory effects on the KB-1TM culture amended with 1,1,1-TCA at a 
concentration of 300 µM and an equimolar concentration of TCE.  Inhibition was also 
documented at a concentration of 30 µM for both 1,1,1-TCA and TCE.  Duhamel et al. 
(13) also reported slowed rates of VC to ethene conversion with KB-1TM at a much lower 
1,1,1-TCA concentration of 5.2 µM.  Some vendors have reported mixed cultures that are 
not inhibited by 1,1,1-TCA (6).  Thus, there is a need to characterize the SRS enrichment 
culture in terms of its susceptibility to inhibition by 1,1,1-TCA. 
 Wood (45) tested the effectiveness of emulsified vegetable oil as an electron 
donor in a biostimulation study, but did not test its feasibility in the bioaugmentation 
study.  Emulsified oil has the added benefit of slower fermentation and longer retention 
in a contaminated aquifer.  Studies have shown the success of emulsified oil as an 
electron donor (30, 31, 50).  Therefore, as part of characterizing the SRS culture, its 
ability to use emulsified vegetable oil as an electron donor was evaluated, in comparison 
to lactate, which is the donor used to maintain the culture.  It was necessary to conduct 
this test in microcosms with soil present, since vegetable oil in groundwater or media 
alone may result in inhibition, presumptively due to accumulation of inhibitory levels of 
long chain organic acids (personal communication from Robert Borden to David 
Freedman).  These fermentation products are not a problem in soil microcosms, since 
they tend to partition to the soil, thereby keeping the aqueous phase concentration low.  A 
soil microcosm test is also more representative of what will occur in situ.  The use of 
emulsified oil as an electron donor as compared to repeat additions of lactate may lower 
the cost of bioaugmentation (17). 
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 Additional characterization of the SRS culture included testing its tolerance to 
oxygen exposure and pH extremes.  Dehalococcoides are strictly anaerobic 
microorganisms, and the success of bioaugmentation cultures in the field is dependent on 
preventing oxygen exposure.  The sensitivity of anaerobic cultures to oxygen is not 
necessarily uniform, as not all cultures are maintained under the same conditions.  In one 
study, Seepersad (39) demonstrated a decrease in the TCE degradation rate of 
microcosms with KB-1 present, when the headspace of the bottles contained 
approximately 0.3 mg/L O2.  Knowledge of the culture’s tolerance to oxygen exposure is 
important to developing a protocol for field deployment, as well as the methods used to 
handle the culture while it is being grown in canisters in the laboratory. 
 In addition to oxygen tolerance, the SRS culture’s sensitivity to a range of pH 
levels is also important for field application of the culture.  The culture has been 
maintained at a pH of 6.5-7.5 in a buffered mineral medium; this is the accepted optimal 
range for most chlororespiring bacteria (32).  KB-1TM has an optimal pH range of 6-8.3 
and is reportedly inhibited below pH 5 and above pH 10 (38).  Zhuang and Pavlostathis 
(51) determined that neutral pH was optimum for reductive dechlorination of PCE to VC 
by a methanogenic mixed culture.  Desulfitobacterium dichloroeliminans strain DCA1, a 
non-Dehalococcoides dehalorespirator, has an optimal pH range of 7.2-7.8, but has 
maintained activity at pH levels as low as 5.4 in the field (33).  The cost to buffer the pH 
of groundwater to neutral may become a large portion of the total bioaugmentation cost.  
Therefore, if the SRS culture is capable of maintaining activity at low pH levels, the cost 
for bioaugmentation may be lessened.  Characterization of the SRS enrichment culture 
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will shed more light on its potential for application at the P-Area chlorinated ethene 
plume at SRS, as well as other contaminated sites. 
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CHAPTER TWO 
RESEARCH OBJECTIVES 
 
 The main objective of this project was to further characterize the SRS enrichment 
culture.  This was accomplished by investigating potential TEAs and culture 
pathogenicity, vulnerability to a known chlorinated inhibitor, use of alternate electron 
donors, and tolerance to oxygen exposure and extreme pH levels.  A large volume of 
culture was also grown in canisters for the purpose of field-scale pilot testing of 
bioaugmentation in the P-Area. 
The specific objectives were: 
1) To design and implement a canister for field deployment of the SRS 
enrichment culture, using the enrichment culture developed from the C-
Area Burning/Rubble Pit microcosms; 
2) To evaluate the range of TEAs used by the SRS enrichment culture, 
including PCE, TCE, cDCE, trans-DCE (tDCE), 1,1-DCE, VC, 1,2-
dichloroethane (1,2-DCA), 1,2-dibromoethane (EDB), and vinyl bromide 
(VB).  In addition to the halogenated ethenes and ethanes, the ability of 
the culture to reductively dechlorinate several chlorinated benzenes was 
tested, including hexachlorobenzene (HCB), pentachlorobenzene (PeCB), 
1,2,4,5-tetrachlorobenzene (1,2,4,5-TeCB), 1,2,4-trichlorobenzene (1,2,4-
TCB), 1,2-dichlorobenzene (1,2-DCB), 1,3-dichlorobenzene (1,3-DCB), 
1,4-dichlorobenzene (1,4-DCB), and chlorobenzene (CB); 
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3) To test the SRS culture for evidence of pathogenicity by assessing its 
ability to grow at 37°C on a rich substrate (trypticase soy broth, or TSB) 
and testing for the presence of total coliforms and E. coli; 
4) To investigate the extent to which 1,1,1-TCA inhibits reductive 
dechlorination of TCE by the SRS enrichment culture; 
5) To compare the culture’s performance while utilizing several Emulsified 
Oil Substrate (EOS®) products to lactate as electron donors in a 
microcosm study using P-Area sediment and groundwater; 
6) To determine the degree to which the enrichment culture can tolerate 
exposure to oxygen; and 
7) To assay the effect of various pH levels (from 5.5 to 8.5) on the SRS 
culture’s ability to reductively dechlorinate PCE and TCE. 
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CHAPTER THREE 
MATERIALS AND METHODS 
 
3.1 Chemicals and Media 
 VC (99.5%) was obtained from Fluka.  Polymer grade ethene (99.9%), purity 
grade ethane (99.95%), and chemically pure grade methane (99%) were obtained from 
Matheson.  PCE (99.9%) and chloroethane (CA) (99.7%) were obtained from Sigma-
Aldrich, TCE (99.5%) from Fisher, cDCE (99%) and 1,1-dichloroethane (1,1-DCA) 
(95%) from TCI America, and tDCE (99.5%), 1,1-DCE (99.5%), and 1,1,1-TCA (99.5%) 
from Chem Services.  EDB (99%) was obtained from Acros Organics and 1,2-DCA 
(99%) from Mallinckrodt.  VB (98%) was obtained from Pfaltz & Bauer. 
 HCB, PeCB, and 1,3,5-TCB were obtained from Chem Services and were all 
99.5% purity.  1,2,4,5-TeCB (98%), 1,2,4-TCB (99%), 1,3-DCB (98%), and CB (99%) 
were obtained from Aldrich, 1,2,3,4-TeCB (98%) and 1,2,3-TCB (99%) from Acros 
Organics, 1,2,3,5-TeCB (99%) from Ultra Scientific, and 1,4-DCB (99%) from Alfa 
Aesar.  1,2-DCB (99.5%) and pesticide grade acetone were obtained from Fisher.  
Dehydrated TSB was obtained from BD Sciences.  Colilert® was obtained from Idexx 
and Readycult® from EMD Chemicals.  Sodium lactate syrup (containing 58.8-61.2% 
sodium lactate; specific gravity = 1.31) was obtained from EM Science.  EOS® 450, 
EOS® 598, and EOS® 598B42 concentrates and EOS® Vitamin B12 solution were 
obtained from EOS Remediation.  All other chemicals used were reagent grade, unless 
indicated otherwise. 
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 The anaerobic mineral medium used to grow the SRS culture was adapted from 
Edwards and Grbić-Galić (14).  Appendix B provides a description of how media was 
prepared.  Note that to achieve a neutral pH, the media must be in contact with a 
headspace of 30% CO2.  This was achieved by sparging the headspace of bottles with a 
gas mixture of 30% CO2 and 70% N2. 
3.2 Culture Maintenance and Development of Canisters 
3.2.1 SRS Enrichment Culture Maintenance 
 The SRS enrichment culture developed by Wood (45) was maintained for use as 
inoculum in the characterization experiments.  The enrichment was maintained in three 
2.6 L glass reagent bottles that were placed in boxes to exclude light.  The reagent bottles 
were sealed with a Teflon-faced rubber septum (35 mm) placed inside a plastic bottle 
cap, which was modified by drilling 24-33 holes (3 mm each) to provide access for a 
syringe for sampling.  This septum was replaced periodically to prevent diffusive losses 
of the volatile compounds.  The bottles were stored in the anaerobic chamber horizontally 
to keep liquid in contact with the septa. 
 These bottles received neat PCE and TCE (resulting in aqueous phase 
concentrations of approximately 15 mg/L and 38 mg/L, respectively) along with lactate 
as the electron donor.  The amount of PCE and TCE added was determined 
gravimetrically by weighing the syringe with PCE or TCE present, then reweighing 
immediately after adding the PCE or TCE to the bottles.  Lactate was added each time the 
enrichment bottles were sampled for headspace analysis and at every PCE and TCE 
feeding.  pH was measured each time PCE and TCE were added and sodium hydroxide (8 
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M) was added as needed to maintain the pH between 6.7 and 7.2.  After every PCE and 
TCE feeding cycle (approximately two weeks), 300 mL of settled liquid (following 1-4 
hours of settling) was decanted from each bottle and replaced with fresh media before the 
addition of PCE, TCE, and lactate. Addition of fresh media provided nutrients and 
avoided accumulation of salt (especially NaCl from neutralization) and sulfide from 
reduction of sulfate in the medium.  Periodically, 100-500 mL of completely mixed liquid 
was removed for use as inoculum in the characterization experiments (see below). 
 At the time of the second canister’s inoculation (see below), 1 L of mixed liquid 
from each of the three enrichment bottles developed by Wood (45) was combined to 
provide 3 L of inoculum for canister #2.  The remaining mixed liquid was redistributed to 
two 2.6 L glass reagent bottles, each of which received 830 mL of mixed liquid and 770 
mL of media; these cultures were referred to as E-3A and E-3B.  The amount of PCE and 
TCE added were scaled down proportionally to the volume of culture present in the two 
new enrichment culture bottles.  Following reduction of the first addition of PCE and 
TCE, the amounts added were gradually increased until the target maximum 
concentrations were reached, i.e., 15 and 38 mg/L, respectively. 
3.2.2 Development of Canisters 
 In preparation for field-scale testing of the enrichment culture in the P-area, the 
SRS enrichment culture (described above) was transferred to two stainless steel canisters 
purchased from Sabco Industries.  The canisters were modified by adding valves for 
media addition, liquid wastage, and headspace analysis (Appendix C).  Prior to adding 
the culture, the canisters were leak-tested under pressure and tested for their ability to 
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retain PCE and TCE (by filling with 18 L of water, adding the compounds, and 
monitoring PCE and TCE levels over several weeks).  No abiotic transformations 
occurred (Appendix C). 
 The inoculum source for the canisters was the SRS enrichment culture that 
actively dechlorinates PCE and TCE to ethene.  The canisters were started by adding 15 
L of media plus 3 L of culture, using a peristaltic pump.  The total liquid volume of 18 L 
allowed for 1 L of headspace.  To maintain anaerobic conditions, the canisters were set 
up in a Coy® anaerobic chamber.  This involved removing the end cap of the chamber, 
quickly placing the canister, culture, and media into the chamber, and resealing the end 
cap.  Once the oxygen level in the chamber reached zero, the culture and media were 
pumped into the canister. 
 After inoculation, neat PCE (30 µL) and TCE (90 µL) were added to the canisters.  
Taking into account partitioning to the headspace, the initial aqueous concentrations were 
3 mg/L of PCE and 7 mg/L of TCE.  These concentrations were increased over time to 
equal the aqueous concentrations added to the enrichment culture maintained in the 2.6 L 
glass bottles (i.e., 15 mg/L PCE and 38 mg/L TCE).  Lactate was added as the sole 
electron donor, whenever PCE and TCE were added, as well as each time a sample was 
taken for headspace analysis.  Each dose of lactate provided 146 mg/L (5 mL of a stock 
solution containing approximately 450 g/L of 60% sodium lactate syrup).  pH was 
measured and adjusted as needed by adding approximately 10 mL of 8 M NaOH along 
with each PCE and TCE addition.  The canisters were incubated at room temperature and 
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on their sides, so that the liquid was in contact with the valves to minimize potential 
losses of the volatile compounds. 
 The canisters were vented periodically to release pressure buildup caused by gas 
production (primarily methane and ethene).  A piece of latex tubing with a needle on one 
end was purged with nitrogen gas to remove air, and then the needle was immediately 
inserted into the Mininert™ valve on the canister (which was standing upright).  The 
open end of the tubing was simultaneously placed into a beaker of water (located in an 
exhaust hood to prevent exposure to the vented gases) to ensure that a positive pressure 
was maintained in the canister, so that room air would not enter.  The venting was 
stopped when gas flow out of the canister nearly stopped. 
 Settled liquid from the canister was removed every fourth or fifth cycle of PCE 
and TCE feeding to prevent accumulation of salts and/or development of a nutrient 
deficiency.  The procedure used for liquid wastage is shown in Figure C.2 (Appendix C).  
The flow of purge gas (30%CO2-70%N2) was controlled through two flow meters, which 
directed gas into the headspaces of the canister and bottle containing fresh media.  The 
canister headspace was purged with the gas mix through the inlet valve on the top of the 
canister.  Simultaneously, a syringe needle connected to tubing was inserted through the 
Mininert™ septum, and the end of the tubing was placed into a beaker of water.  
Bubbling of gas through the water provided verification of proper gas flow.  While 
purging the canister, 3 L of settled liquid was drained by gravity from the top valve on 
the side of the canister; off gases were directed into an exhaust hood, also via tubing 
ending in a beaker of water.  After removing the settled liquid, 3 L of fresh media was fed 
 16 
by gravity into the canister through the outlet valve on top of the canister.  The headspace 
of the media bottle was purged with gas mix to prevent oxygen contamination during 
media addition. 
3.3 Evaluation of Alternate Terminal Electron Acceptors 
 The SRS enrichment culture was evaluated for its ability to grow on a variety of 
halogenated TEAs, falling into two main categories: 1) halogenated alkenes and alkanes; 
and 2) chlorinated benzenes.  The halogenated alkenes and alkanes included PCE, TCE, 
cDCE, tDCE, 1,1-DCE, VC, EDB, 1,2-DCA, and VB.  The chlorinated benzenes 
included HCB, PeCB, 1,2,4,5-TeCB, 1,2,4-TCB, 1,2-DCB, 1,3-DCB, 1,4-DCB, and CB.  
Alternate TEA experiments were conducted in 160 mL serum bottles containing media 
and the SRS enrichment culture (E-3A and E-3B) as inoculum. 
3.3.1 Evaluation of Halogenated Alkenes and Alkanes as TEAs 
 The alternate TEA experiment with halogenated alkenes and alkanes was 
conducted in two phases.  For Phase 1, serum bottles were prepared with 80 mL of media 
and 20 mL of inoculum from the 2.6 L enrichment culture bottles grown on PCE and 
TCE.  Addition of compounds to the Phase 1 bottles was stopped when 500 µmol of 
chloride or bromide had been released per bottle.  At this point the bottles were shipped 
(on ice) by an overnight carrier to Dr. Bagwell at SRNL.  Phase 2 serum bottles were 
prepared with 99.9 mL of media and 0.1 mL of inoculum.  The sources of inoculum for 
Phase 2 serum bottles varied and are summarized in Figure 3.1.  Addition of compounds 
to the Phase 2 bottles was stopped when 200 µmol of chloride or bromide was released 
per bottle.  As with the Phase 1 bottles, the Phase 2 bottles were then shipped (on ice) by 
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an overnight carrier to Dr. Bagwell.  The only exception to this experimental protocol 
was the treatment that received VB as the TEA.  There was no Phase 1 step for VB; 
instead these bottles were started directly with 0.1% inoculum from the Phase 2 bottles 
that received EDB (Figure 3.1). 
 Lactate was used as the electron donor, consistent with what the SRS enrichment 
culture received.  It was added at the same time as addition of the test compound and at 
every headspace analysis.  The total amount of lactate added was more than 100 times 
higher than the electron donor needed for stoichiometric dehalogenation of the TEA.  A 
stock solution of 60% sodium lactate syrup was prepared (approximately 450 g/L) so that 
the intended amount of donor was added in 0.1 mL of the stock solution. 
 Live treatments were prepared in an anaerobic chamber with an atmosphere of 
approximately 98% N2 and 2% H2.  Aseptic techniques were used during preparation of 
the live treatments.  After adding media and inoculum, the bottles were sealed with 
Teflon-faced red rubber septa and aluminum crimp caps, with the exception of the ones 
that received VC, which were sealed with slotted gray butyl rubber septa.  The bottles 
were then removed from the anaerobic chamber, sparged with a 30%CO2-70%N2 gas 
mixture, and spiked with the appropriate compound.  The initial amounts of TEAs added 
are shown in Table 3.1.  The first addition of PCE and TCE was 20% of the amount fed 
to the SRS enrichment culture, to account for dilution of the inoculum.  The amounts of 
all other TEAs added was within the range of PCE and TCE added, except for EDB, 
which was slightly lower. 
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 After a compound was consumed, the subsequent amount added was gradually 
increased until the target maximum was reached (Table 3.1).  The target maxima were 
similar to the maximum concentrations of PCE and TCE added to the SRS enrichment 
culture during routine operation (section 3.2.1). 
 Halogenated alkenes and alkanes were initially added to the serum bottles using 
saturated solutions.  When the amount of saturated water that was needed exceeded 1 mL, 
neat liquid was used instead (to avoid diluting the contents of the serum bottles).  The 
amounts of neat compound required to reach the maximum concentrations (17-39 mg/L) 
are also shown in Table 3.1.  The only exceptions were for VC and VB, which were 
always added as neat gases (using a 1.0 mL Pressure-Lok® gas syringe).  The live 
treatments were incubated in an inverted position (i.e., liquid in contact with the septum) 
at room temperature (21-24oC) and in boxes (to exclude light) in the anaerobic chamber, 
except during headspace analysis.  Neutral pH was maintained by measuring pH and 
adding NaOH (8 M) at each feeding, corresponding to the amount of acid released by 
dehalogenation. 
 For the experiments with halogenated alkenes and alkanes, the concentration of 
Dehalococcoides was determined at the start of the experiment and after repeated cycles 
of compound consumption to determine if it was used as a TEAs and, if so, to calculate a 
yield.  Quantitative polymerase chain reaction (qPCR) was used to determine the 
Dehalococcoides concentrations.  This work was completed by Dr. Bagwell at the SRNL. 
 In addition to the live treatments, two sets of water controls (WCs) were set up to 
evaluate the extent of abiotic losses via diffusion through the septa.  WCs consisted of 
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100 mL of distilled, deionized (DDI) water plus the volatile organic compounds.  One set 
received PCE + TCE + cDCE + VC + ethene.  A second set of WCs received 1,1-DCE + 
tDCE + methane.  A third set of WCs received 1,2-DCA, EDB and VB.  The same initial 
quantities of compounds added to the live treatments (Table 3.1) were added to the WCs.  
Ethene and methane were added in the same volume as VC.  The WCs were prepared and 
incubated on the bench top with room air present in the headspace.  All bottles were 
incubated in an inverted position (liquid in contact with the septa), at room temperature 
(21-24oC), and in boxes (to exclude light). 
3.3.2 Reductive Dechlorination of Chlorinated Benzenes  
 For the experiment to evaluate if the SRS culture is able to reductively 
dechlorinate chlorinated benzenes, there was only one phase, i.e., only one set of 
treatments was prepared per compound and no transfers were made.  The experiment was 
performed in serum bottles that received 20 mL of the SRS culture and 80 mL of media.  
Live treatments were prepared in an anaerobic chamber.  Aseptic techniques were used 
during preparation.  After adding media and inoculum, the bottles were sealed with 
Teflon-faced red rubber septa and aluminum crimp caps.  They were then removed from 
the anaerobic chamber, sparged with a 30%CO2-70%N2 gas mixture, and spiked with the 
appropriate compound.  The initial amounts added are shown in Table 3.1. 
 Chlorinated benzenes were added to the serum bottles in two ways: as a neat 
liquid (for  1,2-DCB, 1,3-DCB, and CB) and as a stock solution dissolved in acetone (for 
1,4-DCB, HCB, PeCB, and 1,2,4,5-TeCB).  The latter method was modified from 
Holliger et al. (27), who delivered chlorinated benzenes dissolved in pentane rather than 
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acetone.  The two-phase liquid method for providing chlorinated benzenes used by 
Fennell et al. (19) was considered but rejected, due to interference caused by the pentane 
with headspace analysis on the gas chromatograph (GC). 
 A concern with delivering 1,4-DCB, HCB, PeCB, and 1,2,4,5-TeCB in acetone 
was the potential influence of acetone on performance of the SRS enrichment culture.  A 
preliminary experiment with the enrichment culture was conducted to test the effect of 
acetone on the culture’s dehalogenation activity on PCE and TCE.  The experiment 
consisted of two treatments: 
 1)  PCE + TCE; and 
 2)  PCE + TCE + acetone. 
 Both treatments were prepared in triplicate, in 160 mL serum bottles, with 80 mL 
of media and 20 mL of enrichment culture.  After adding the culture and media in the 
anaerobic chamber and sealing the bottles, they were removed and sparged with a 
30%CO2-70%N2 gas mixture.  Both treatments received an initial dose of PCE (2.2 µmol) 
and TCE (7.4 µmol), which was 20% of what the enrichment culture routinely receives, 
to account for dilution of the inoculum.  The treatment without acetone served as a 
positive control, to confirm the culture’s ability to dechlorinate PCE and TCE.  All six 
bottles were initially given PCE, TCE and lactate.  When the PCE and TCE were 
completely consumed, PCE and TCE were added at the maximum concentrations 
provided to the enrichment culture, along with additional lactate.  Three of the bottles 
also received 70 µL of acetone, which is the same volume used for delivering the stock 
solution of HCB.  In the three bottles with acetone added, reductive dechlorination of 
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PCE and TCE occurred at the same rate as the bottles without acetone added (Appendix 
D), indicating that the addition of acetone does not interfere with the dechlorination 
capability of the SRS culture.  The possibility that acetone might benefit the culture by 
serving as an additional electron donor was not explored. 
 In addition to the live treatments, WCs and autoclaved controls were prepared. 
One set of WCs contained DDI water + HCB + PeCB + 1,2,4,5-TeCB; a second set 
contained DDI water + 1,2,4-TCB + 1,3-DCB; and a third set contained DDI water + 1,4-
DCB + 1,2-DCB + CB.  Chlorinated benzenes were added in the same quantity as those 
initially added to the live treatment bottles (Table 3.1).  The WCs were prepared and 
incubated on the bench top with room air present in the headspace.  Autoclaved controls 
were prepared to determine if decreases in the chlorinated benzenes were attributable to 
adsorption to biomass.  Like the live treatments, the bottles were set up in the anaerobic 
chamber and contained 80 mL of media and 20 mL of enrichment culture.  The bottles 
were then autoclaved for 20 min at 121oC.  After the bottles cooled to room temperature, 
HCB, PeCB, and 1,2,4,5-TeCB were added in the same volumes as the live treatments. 
 All bottles were sealed with Teflon-faced red rubber septa and aluminum crimp 
caps and incubated in an inverted position (liquid in contact with the septa), at room 
temperature (21-24oC), and in boxes (to exclude light).  The live bottles were incubated 
in the anaerobic chamber to minimize the possibility for introduction of oxygen. 
3.4 Evaluation of Pathogenicity 
 The original inoculum source for the SRS culture was wetland sediment, with no 
known exposure to human pathogens.  Enrichment of the culture over several years by 
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providing high concentrations of PCE and TCE in a defined anaerobic mineral medium 
further suggests that culture conditions are not conducive to survival of pathogens.  
Nevertheless, the SRS culture was tested for the presence of pathogens.  Two approaches 
were used. 
 First, the ability of the culture to grow aerobically on a rich substrate (TSB) was 
evaluated at 37°C.  If growth did not occur at this temperature, it would be reasonable to 
assume that human pathogens were absent.  For this test, three treatments were used: 
 1) TSB inoculated with activated sludge, to serve as a positive control;  
 2) TSB inoculated with sterile DDI water, to serve as a negative control; and  
 3) TSB inoculated with the SRS culture.   
 All treatments were prepared in triplicate in 500 mL Erlenmeyer flasks containing 
250 mL of sterile TSB and stoppered with sterile foam plugs.  Inocula were delivered 
aseptically using a sterile 1.0 mL syringe.  Oxygen was provided by agitating the liquid 
using a magnetic stirrer and stir bar.  The treatments were incubated in a Napco 330 
incubator for 48 hours at 37oC.  Culture growth was indicated by an increase in turbidity. 
 As the results will show, growth of the SRS culture in TSB did occur at 37°C, so 
the second approach used was to test for the presence of coliforms and E. coli.  This was 
accomplished using two commercial testing kits, Colilert® and ReadyCult®.  Colilert® 
simultaneously detects total coliforms and E. coli by utilizing the two nutrient indicators, 
ortho-nitrophenyl-β-D-galactopyranoside (ONPG) and 4-methylumbelliferyl-β-D-
glucuronide (MUG).  As coliforms grow in Colilert®, they use β-galactosidase to 
metabolize ONPG into ortho-nitrophenol, which results in a color change in the media 
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from colorless to yellow.  If E. coli are present, they use β-glucuronidase to hydrolize 
MUG into 4-methylumbelliferone, which fluoresces at 366 nm.  ReadyCult® media 
contains 5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside (X-Gal) and MUG.  The 
activity of β-galactosidase on X-Gal produces a blue-green color to indicate the presence 
of total coliforms and hydrolysis of MUG serves as an indicator of E. coli, as with 
Colilert®. 
 Four treatments were set up with Colilert® media: 
 1) raw sewage, to serve as a positive control for the presence of coliforms and E. 
coli; 
 2) sterile DDI water, to serve as a negative control; 
 3) autoclaved sewage, also to serve as a negative control; and 
 4) the SRS culture. 
 All treatments were prepared in triplicate in sterile 125 mL Erlenmeyer flasks 
containing 45 mL of DDI water and stoppered with foam stoppers.  A 5 mL disposable 
syringe was used to deliver 5 mL of the respective inocula.  The Colilert® media was then 
added by pouring in the contents of a sterile snap pack.  The flasks were thoroughly 
mixed and incubated aerobically in a Napco 330 incubator for 24 hours at 37oC.  The 
flasks were observed for a color change from clear to yellow.  Samples that turned yellow 
(indicating a positive test for total coliforms) were then checked for fluorescence with a 
365 nm UV light source to test for presence of E. coli. 
 Three treatments were set up with Readycult® media: 
 1) a positive control (raw sewage); 
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 2) a negative control (sterile DDI water); and 
 3) the SRS enrichment culture. 
 The treatments were set up in triplicate and prepared aseptically in sterile 125 mL 
Erlenmeyer flasks sealed with foam stoppers, or in 100 mL sterile sample bottles pre-
filled with Readycult® media.  All flasks and sample bottles received 90 mL of DDI water 
and 10 mL of the respective inocula to give a total sample volume of 100 mL.  After 
adding the inoculum to the flasks, the Readycult® media was added using a sterile snap 
pack and then the contents were mixed well.  The flasks and sample bottles were 
incubated aerobically in a Napco 330 incubator for 24 hours at 37oC and were then 
observed for a color change from clear to blue-green.  Water samples that turned blue-
green (indicating a positive test for total coliforms) were then illuminated with a 365 nm 
UV light source to test for fluorescence (indicating the presence of E. coli).  A Colilert® 
comparator was used to verify fluorescence of samples. 
3.5 Inhibition of TCE Reductive Dechlorination by 1,1,1-TCA 
 Two sets of experiments were performed to test if reductive dechlorination of 
TCE by the SRS enrichment culture is inhibited by the presence of 1,1,1-TCA.  Phase 1 
involved the use of undiluted SRS culture and a high initial concentration of 1,1,1-TCA 
(300 µM).  Three treatments were prepared: 
 1)  SRS culture + 300 µM TCE; 
 2)  SRS culture + 300 µM TCE + 300 µM 1,1,1-TCA; and 
 3)  DDI water + 300 µM TCE + 300 µM 1,1,1-TCA. 
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 Grostern and Edwards (23) documented inhibitory effects on the KB-1TM culture 
at a similar concentration of 1,1,1-TCA.  The TCE-only treatment served as a control to 
demonstrate the culture’s ability to dechlorinate TCE.  Both live treatments were set up in 
160 mL serum bottles with 100 mL of undiluted SRS culture.  Lactate was used as the 
electron donor, with the amount added at least 100 times greater than the amount needed 
for stoichiometric reduction of the TCE and 1,1,1-TCA.  WCs were prepared with 100 
mL of DDI water and both compounds.  The WCs were used to estimate initial 
concentrations of TCE and 1,1,1-TCA in the live bottles, since dechlorination of the TCE 
was too rapid to permit a time zero measurement (data not shown). 
 As the results will show, 1,1,1-TCA inhibited the complete reduction of TCE in 
the Phase 1 experiment.  To better define the concentration of 1,1,1-TCA required to 
cause inhibition, a Phase 2 experiment was performed.  In this case, the SRS culture was 
diluted in order to slow the rate of TCE dechlorination and lower concentrations of 1,1,1-
TCA were added.  The treatments consisted of: 
 1)  SRS culture (10% v/v) + media + 31 µM TCE; 
 2)  SRS culture (10% v/v) + media + 31 µM TCE + 0.7 µM 1,1,1-TCA; 
 3)  SRS culture (10% v/v) + media + 31 µM TCE + 3.6 µM 1,1,1-TCA; 
 4)  SRS culture (10% v/v) + media + 31 µM TCE + 18 µM 1,1,1-TCA; and 
 5) Water controls, consisting of DDI water + 31 µM TCE, along with 18 µM each 
of 1,1,1-TCA, CA, and ethene. 
 The four live treatments were prepared in 160 mL serum bottles with 90 mL 
minimal media and 10 mL of SRS enrichment culture; this level of inoculum was 
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consistent with that used by Duhamel et al. (13) and Grostern and Edwards (23).  Lactate 
was used as the electron donor and the amount added was at least 100 times greater than 
the amount needed for stoichiometric reduction of the TCE and 1,1,1-TCA for all live 
treatments.  As with the Phase 1 experiments, WCs were set up to evaluate the extent of 
diffusive losses. 
 For Phases 1 and 2, live treatments were prepared in an anaerobic chamber with 
an atmosphere of approximately 98% N2 and 2% H2.  Aseptic techniques were used.  The 
bottles were sealed with Teflon-faced red rubber septa, removed from the chamber, and 
the headspaces were sparged with a 30%CO2-70%N2 gas mixture.  The live treatments 
were incubated in the anaerobic chamber except during headspace analysis.  The WCs 
were prepared and incubated on the bench top with room air present in the headspace.  
All bottles were incubated in an inverted position (liquid in contact with the septa), at 
room temperature (21-24oC), and in boxes (to exclude light). 
3.6 Microcosm Evaluation of EOS® as Electron Donor 
 The only electron donor evaluated thus far for the SRS enrichment culture is 
lactate.  The intent of this experiment was to evaluate several EOS® products, the primary 
ingredient of which is emulsified vegetable oil.  Fermentation of vegetable oil typically 
yields long chain fatty acids that are potentially inhibitory to anaerobic microbes.  To 
avoid this toxicity issue, the vendor recommended that use of EOS® be evaluated in 
microcosms with soil present, rather than adding EOS® directly to the enrichment culture 
in media.  Soil provides adsorption sites for the long chain fatty acids, thereby lowering 
their aqueous solubility and minimizing the risk of inhibition. 
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 Six treatments were prepared using soil samples and groundwater from the P-
Area: 
 1) addition of lactate without bioaugmentation; 
 2) addition of lactate plus bioaugmentation with 1.0% (v/v) of SRS enrichment 
culture; 
 3) addition of EOS® 450 plus bioaugmentation with 1.0% (v/v) of SRS 
enrichment culture; 
 4) addition of EOS® 598 plus bioaugmentation with 1.0% (v/v) of SRS 
enrichment culture; 
 5) addition of EOS® 598B42 plus bioaugmentation with 1.0% (v/v) of SRS 
enrichment culture; and 
 6) addition of EOS® 598 and EOS® Vitamin B12 solution plus bioaugmentation 
with 1.0% (v/v) of SRS enrichment culture. 
 The groundwater was first amended with nutrients (N, P, Mg2+, Ca2+, Fe2+, and 
micronutrients) in the same ratio that these compounds are added to the minimal media 
(i.e., per liter of groundwater:  10 mL phosphate buffer, 10 mL salts solution, 2 mL trace 
metals solution, 2 mL magnesium sulfate solution, and 10 mL yeast extract solution).  
The pH of the nutrient-amended groundwater was then adjusted from 6.75 to 7.00 by 
addition of 15 mL of a sodium bicarbonate solution (16 g/L NaHCO3) and 1 mg/L 
resazurin was added as a redox indicator.  pH adjustment created optimal conditions for 
chlororespiration of PCE and TCE by the SRS enrichment culture. 
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 Microcosms were prepared in 160 mL serum bottles, and all treatments were set 
up in triplicate.  All of the microcosms were prepared in an anaerobic chamber with an 
atmosphere of approximately 98% N2 and 2% H2; aseptic techniques were used during 
preparation.  The microcosms consisted of 20 g of soil (wet weight) plus 50 mL of 
nutrient amended and pH adjusted groundwater, minus the liquid volume needed for 
adding PCE and TCE as saturated water solutions (1.0 mL and 2.5 mL, respectively).  
The initial aqueous-phase concentrations (taking into account partitioning between the 
headspace and liquid phases) were approximately 2.5 mg/L PCE and 35 mg/L TCE.  
These are the same initial concentrations used in the microcosm experiments by Wood 
(45) to evaluate use of the SRS culture for bioaugmentation.  The microcosms were 
monitored for a change in the color of the groundwater from pink to clear, indicating the 
establishment of a low redox level.  Bioaugmentation with the SRS enrichment culture 
occurred after low redox levels were reached in all of the microcosms. 
 The procedures used to prepare EOS® products for addition to the EOS®-amended 
treatments was performed in accordance with vendor recommendations for microcosm 
studies.  A 1:10 dilution of EOS® 450, EOS® 598, and EOS® 598B42 was prepared by 
adding 10 mL of EOS® to 90 mL of unadjusted P-Area groundwater.  The respective 1:10 
EOS® dilution was then further diluted fifty times by adding 0.95 mL to microcosms 
containing 50 mL of adjusted groundwater and 20 g soil.  This process resulted in a 1:500 
final dilution for all EOS® products.  EOS® Vitamin B12 solution (15 µL) was added to 
treatment #6, in accordance with vendor instructions.  The amount of lactate added to 
treatments #1 and #2 was the same as that added during the nutrient microcosm study by 
 29 
Wood (i.e., 0.1 mL of a stock solution containing approximately 450 g/L of 60% sodium 
lactate solution) (45). 
3.7 Oxygen Tolerance 
 A potential issue for successful delivery of the SRS enrichment culture in the field 
is its sensitivity to oxygen, since some exposure is possible.  The effect of oxygen 
exposure on the culture’s ability to dechlorinate PCE and TCE was investigated.  This 
was done in two experiments:  Phase 1 consisted of a preliminary evaluation to establish 
the range of possible times the culture could be exposed to oxygen.  Three serum bottles 
received 100 mL of the SRS culture.  One bottle was not exposed to air and thereby, 
served as a positive control.  A second bottle was left open to the atmosphere for 12 hours 
and a third was left open for 24 hours (without agitation).  All bottles were then recapped, 
spiked with PCE, TCE, and lactate (at the same levels routinely added to the enrichment 
culture) and monitored. 
 As the first round of testing will show (Appendix E), exposure to air slowed the 
onset of reductive dechlorination but did not prevent it.  Consequently, a second round of 
testing (Phase 2) was performed.  Two treatments were prepared in 160 mL serum bottles 
with 80 mL of media and 20 mL of enrichment culture, providing a 20% inoculum; both 
treatments were prepared in triplicate.  The bottles were prepared in an anaerobic 
chamber with an atmosphere of approximately 98% N2 and 2% H2.  Aseptic techniques 
were used.  One set was not exposed to air and the other set was exposed to air for 24 
hours by leaving the bottles open to the atmosphere (without agitation).  After 24 hours, 
the bottles were recapped, and the pH of all bottles was adjusted to neutral with 8 M 
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NaOH.  PCE-saturated water (2.4 mL) and TCE-saturated water (0.9 mL) were added to 
both treatments along with lactate as the electron donor.  The decrease in percent oxygen 
in the headspace of the bottles exposed to air was measured using a gas chromatograph 
equipped with a thermal conductivity detector (see section 3.11).  The initial percent 
oxygen in the headspace of the 24-hour exposure treatment bottles was assumed to be 
21%. 
3.8 pH Tolerance 
 The SRS enrichment culture is maintained within a pH range of 6.5 to 7.5, which 
is comparable to similar chlororespiring cultures.  Since field pH levels may not be 
within this range and the cost of controlling in situ pH may be high, it was of interest to 
know how the SRS enrichment culture would respond to a range of pH levels.  The 
experiment consisted of six treatments: 
 1) pH 5.5; 
 2) pH 6.0; 
 3) pH 6.5; 
 4) pH 7.0; 
 5) pH 8.5; and 
 6) pH 7.0 with no adjustment. 
 Each treatment consisted of triplicate 160 mL serum bottles that received 84 mL 
of media and 21 mL of the SRS enrichment culture.  The extra 5 mL of liquid (i.e., 105 
mL total rather than 100 mL) was added to allow for removing samples for pH 
adjustment.  After capping the bottles with Teflon-lined septa in the anaerobic chamber, 
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they were removed and the headspaces were sparged with the 30%CO2-70%N2 gas 
mixture.  The serum bottles were returned to the anaerobic chamber where 1 mL samples 
were removed with a syringe and used to check the pH following additions of 8 M NaOH 
or 6 M HCl (the pH meter was also moved into the anaerobic chamber); see section 3.10.  
Once the correct pH level was attained, PCE and TCE were added outside the chamber 
(2.4 and 0.9 mL of saturated water, respectively) along with lactate as the electron donor. 
 pH levels were maintained within ±0.25 pH units of the target for the first five 
treatments by acid or base addition each time the bottles were sampled for headspace 
analysis.  This was accomplished by adding 2 mL of media to the bottles, withdrawing a 
1 mL sample to measure the pH, addition of acid or base, and withdrawal of a second 1 
mL sample to confirm the pH.  Media was added prior to each measurement in order to 
maintain a constant liquid volume in the bottle and avoid altering the pH after acid or 
base adjustment.  No acid or base was added to treatment #6, i.e., an initial pH of 7.0 with 
no further pH adjustment, in order to observe the culture’s reaction to a gradual decrease 
in pH. 
 The serum bottles were incubated in the anaerobic chamber except during 
headspace analysis.  All bottles were incubated in an inverted position (liquid in contact 
with the septa), at room temperature, (21-24oC), and in boxes (to exclude light).  At least 
once per week, the pH of the bottles was measured and adjusted as described above. 
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3.9 Volatile Organic Compound Analysis 
3.9.1 Halogenated Alkenes and Alkanes 
 The chlorinated ethenes, 1,1,1-TCA, 1,1-DCA, CA, 1,2-DCA, EDB, 
bromoethane, VB, ethene, ethane, and methane were monitored by headspace analysis 
using a Hewlett Packard Series II 5890 GC.  The mass of each compound present in a 
bottle was determined by analysis of a 0.5 mL headspace sample, using a flame 
ionization detector (FID) in conjunction with a column packed with 1% SP-1000 on 
60/80 Carbopack-B (Supelco, Inc.).  The carrier gas used was nitrogen (21). 
 Two sets of standards were prepared.  One set was used for experiments in which 
the serum bottles contained 100 mL of liquid and no soil.  For this type of system, 
standards were prepared by adding known amounts of each compound to 160 mL serum 
bottles containing 100 mL DDI water.  The number of moles of gases added was 
calculated using the ideal gas law, based on the volume added at room temperature and 
atmospheric pressure.  A stock solution of PCE, TCE, cDCE, and 1,1-DCE was prepared 
gravimetrically in methanol.  A separate stock solution of tDCE was also prepared, as it 
has the same retention time as cDCE.  After adding known amounts of the gases and 
stock solution to the serum bottles, the bottles were incubated for 1-4 hours.  This 
allowed sufficient time for the compounds to equilibrate but not enough time for 
significant biotic and abiotic losses to occur.  Peak areas obtained from headspace 
analysis were used to determine response factors (RFs) for each compound, in terms of 
the total mass per bottle per peak area unit from a 0.5 mL headspace sample.  Standards 
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were prepared in the same manner for the halogenated alkanes.  RFs and minimum 
detection limits are shown in Appendix F. 
 The second set of standards was used for the microcosm experiment evaluating 
EOS as an electron donor.  For this type of system, standards were prepared by adding 50 
mL of DDI water plus several glass beads to the serum bottles.  The amount of glass 
beads added was equivalent to the same volume of liquid displaced as 20 g of soil 
(approximately 11 mL).  The same procedures described above were then used to add the 
volatile compounds and determine RFs for the microcosms, which are shown in 
Appendix G. 
 A separate set of standards was prepared for the canisters, since they contain a 
different ratio of liquid to headspace volume compared to the serum bottles.  The liquid 
standards (cDCE, TCE, and PCE) were prepared in 70 mL serum bottles, using the same 
ratio of headspace and liquid as in the canisters (i.e., 1.6 L:18 L), and the gas standards 
(VC, ethene, and methane) were prepared in 160 mL serum bottles, using the same ratio 
(i.e., 1.6 L:18 L).  The same procedures described above were then used to add the 
volatile compounds and determine RFs (Appendix H).  To obtain RFs for the canisters, 
the RFs for the 70 mL serum bottles and 160 mL serum bottles were multiplied by the 
ratio of the total volumes, i.e. 
 Canister RFs = 70 mL Serum Bottle RFs x (19600 mL/70 mL) (3.1) 
 Canister RFs = 160 mL Serum Bottle RFs x (19600 mL/160 mL) (3.2) 
 The GC response to a headspace sample was calibrated to give the total mass of 
the compound (M) in that bottle.  Assuming that the headspace and aqueous phases are in 
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equilibrium, the total mass present was converted to an aqueous phase concentration as 
follows: 
 
Cl =
M
Vl + HcVg
 (3.3) 
where Cl = concentration in the aqueous phase (µM); M = total mass present 
(µmol/bottle); Vl = volume of the liquid in the bottle (0.1 L for the experimental bottles, 
18 L for the canisters, and 0.05 L for the microcosms); Vg = volume of the headspace in 
the bottle (0.06 L for the experimental bottles, 1.6 L for the canisters, and .099 L for the 
microcosms); and Hc = Henry's constant (dimensionless) at 23°C (see Table 3.1). 
3.9.2 Chlorinated Benzenes 
 CB, DCB isomers, and 1,2,4-TCB were also quantified by analysis of 0.5 mL 
headspace samples, using a Hewlett Packard Series II 5890 plus GC equipped with an 
Rtx 5 column (30m x 0.53 mm x 1.5 µM film) and FID.  The injector and detector 
temperature were set at 250°C and 325°C, respectively.  An isothermal oven temperature 
program was set at 120°C for 9 min. The retention times for CB, 1,3-DCB, 1,4-DCB, 1,2-
DCB, and 1,2,4-TCB were 2.0, 3.4, 3.5, 3.9, and 7.4 min, respectively.  Helium (5 
mL/min) was used as carrier gas, nitrogen (30 mL/min) served as the make-up gas, and 
hydrogen and air (40 mL/min and 210 mL/min, respectively) were used as the fuel for the 
FID. 
 HCB, PeCB, and 1,2,4,5-TeCB were quantified on a ZB 624 capillary column (30 
m x 0.53 mm x 3.0 µm film) using an electron capture detector (ECD) in order to 
improve their detection limits, since these compounds are not sufficiently volatile to 
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measure by FID at the concentrations tested.  An isothermal program was used (240°C), 
during which 1,2,4,5-TeCB, PeCB, and HCB eluted at 6.3, 9.1, and 13.9 min, 
respectively.  Detection limits for all chlorinated benzenes are shown in Table I.1 
(Appendix I). 
 Standards for the serum bottles were prepared by adding known amounts of each 
compound to 160 mL serum bottles containing 100 mL of DDI water.  Stock solutions of 
the chlorinated benzenes were prepared gravimetrically in acetone (since the compounds 
are not adequately soluble in methanol).  Separate stock solutions of the dichlorobenzene 
isomers were prepared due to the overlap of their retention times on the ZB 624 column.  
After adding a known amount of the stock solution to the serum bottles, they were 
incubated for 1-4 hours.  This allowed sufficient time for the compounds to equilibrate 
but not enough time for significant biotic and abiotic losses to occur.  Peak areas obtained 
from headspace analysis were used to determine RFs for each compound, in terms of the 
total mass per bottle per peak area unit from a 0.5 mL headspace sample (Appendix I).  
Equation 3.2 was used to convert mass per bottle to aqueous phase concentrations. 
3.10 pH Analysis and Adjustment 
 The pH of the enrichment cultures maintained in the 2.6 L glass bottles and 
canisters was measured in 1 mL samples using a Corning 345 pH meter.  The pH meter 
was calibrated before samples were analyzed using pH 7 and 10 buffer solutions.  Using a 
1.0 mL gas-tight syringe, a 1 mL sample of mixed liquid was put in a test tube, and initial 
pH was checked with the pH meter.  NaOH (8 M) was added incrementally to the 
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canisters to adjust pH; after each 8 M NaOH addition, the pH was checked and adjusted 
until the pH reached neutral. 
 The pH of the liquid in serum bottles was analyzed using pH test strips.  Baker-
pHIX strips were used for the pH range of 6.0 to 7.7, in 0.3 pH unit increments.  Using a 
100 µL gas-tight syringe, a 10 µL drop was placed on the test strip and the color was read 
approximately 3 sec after contact.  The only exception to this pH analysis method was 
with the pH tolerance experiment; see section 3.8. 
3.11 Oxygen Analysis 
 Oxygen was analyzed by gas chromatographic analysis of 0.1 mL headspace 
samples. A Hewlett Packard 5890 Series II GC was used, equipped with a thermal 
conductivity detector set at low sensitivity.  The GC was equipped with a Molecular 
Sieve 5A column (3.175 mm x 1.829 m, Alltech).  The oven was held at 70ºC and the 
injector and detector at 120ºC.  Helium served as both the reference (30 mL/min) and 
carrier gas (30 mL/min).  Triplicate room air samples (0.1 mL) were used to develop a 
response factor (i.e., percent oxygen per GC peak area unit).  It was assumed that the 
detector response was linear over the range tested (i.e., 0-21% O2).  The sample peak 
area was multiplied by the response factor to determine the percent oxygen in the 
headspace of the bottles. 
 To minimize contamination of the sample with room air, samples were taken 
inside the anaerobic chamber.  The tip of the syringe needle was then pushed into a gray 
butyl rubber septum so that the tip of the needle was covered.  The syringe was removed 
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from the chamber and taken to the GC, where the needle was pushed through the gray 
butyl rubber septum directly into the injection port of the GC. 
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CHAPTER FOUR 
RESULTS 
 
4.1 Canister Development 
 Two canisters were set up as described in section 3.2.2.  The canisters were 
prepared identically with inoculum from the 2.6 L enrichment bottles.  Canisters #1 and 
#2 took 20 and 31 days to completely dechlorinate the PCE and TCE from the first 
addition, respectively, after no apparent lag (Figures 4.1 and 4.2).  cDCE and VC 
accumulated transiently and then decreased as ethene increased.  Ethene was the major 
terminal product.  PCE and TCE concentrations were increased at every addition until the 
target PCE (15 mg/L) and TCE (38 mg/L) concentrations were reached.  The same trend 
of dechlorination continued over subsequent additions with little accumulation of cDCE 
and VC.  When the canisters were vented or media was wasted, the rate of PCE and TCE 
dechlorination did not decrease.  The cumulative amount of ethene produced was larger 
than the cumulative amount of PCE and TCE added to the canisters (Figures 4.3 and 4.4).  
The average molar ratio of ethene to PCE + TCE was 1.16 for canister #1 and 1.48 for 
canister #2.  Standards were not prepared using the canisters; therefore, error associated 
with the ethene response factor for the canisters is most likely the cause of the higher than 
expected molar ratios.  Results for the leak tests of both canisters showed no abiotic 
losses of PCE or TCE (Appendix C) when incubated with only DDI water and no live 
enrichment culture.  Canister #1 and canister #2 were successfully maintained for 513 
and 329 days, respectively. 
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4.2 Yield Experiment:  Chlorinated Ethenes and Halogenated Ethanes 
 As explained in section 3.3, the experiment to determine if various halogenated 
compounds are used as terminal electron acceptors by the SRS enrichment culture was 
conducted in two phases.  Phase 1 was started with a 20% (v/v) inoculum from the 
enrichment that was being maintained with PCE and TCE, while Phase 2 was started with 
a 0.1% (v/v) inoculum.  Results for Phase 1 are presented first, followed by Phase 2 and 
then a description of the yield coefficients. 
4.2.1 Phase 1 
 Results for the triplicate bottles that received PCE as the sole chlorinated terminal 
electron acceptor are shown in Figures 4.5-4.7.  Following a brief lag of six days, all of 
the bottles started rapidly consuming PCE.  The amount of PCE added was increased and 
the rate of utilization responded accordingly.  An increasing rate of utilization over time 
is consistent with cultures that use a compound as a terminal electron acceptor.  Over the 
first 56 days of incubation, there was no apparent accumulation of TCE.  Relatively low 
amounts of cDCE and VC appeared and then declined with each cycle of PCE 
consumption.  Ethene was the predominant daughter product.  This pattern of activity 
was expected, since the SRS culture had been maintained on PCE and TCE as electron 
acceptors for several years. 
 However, with the fifth addition of PCE, there was a notable decline in the 
performance of the culture.  The rate of PCE dechlorination slowed considerably.  After 
reviewing the manner in which the cultures were being maintained, one oversight in 
particular became apparent:  No action was being taken to neutralize the HCl released 
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during PCE dechlorination.  On day 95, the pH of all three bottles was found to be less 
than 6.0, which is generally considered too low for most chlororespiring cultures.  The 
pH was raised to 6.7-7.0 by adding 0.25-0.30 mL of 8 M NaOH.  Lactate additions 
continued during this interval, and despite the pH being less than 6.0, methanogenesis 
continued.  This led to a considerable build up of pressure in the bottles.  To alleviate 
this, the bottles were vented on day 120.  This explains the vertical drop in methane, 
PCE, and ethene on day 120.  Thereafter, there was only a limited improvement in the 
rate of PCE reduction.  Apparently, the culture was unable to recover from the low pH 
episode. 
 Table 4.1 summarizes the performance of the Phase 1 cultures in terms of the 
stoichiometry of ethene formation and the percentage of lactate added (based on electron 
equivalents) that was used for the respective TEA’s reduction to ethene.  For PCE, an 
average of 89% of the amount consumed was recovered as ethene and only 0.32% of 
electron equivalents of the lactate added was consumed for reductive dechlorination. 
 Figures 4.8-4.10 present the results for triplicate bottles that received TCE as the 
sole chlorinated terminal electron acceptor.  As with PCE, rapid utilization of TCE 
started after a brief lag period.  The amount of TCE added was increased, and the rate of 
utilization responded accordingly through day 40.  Ethene was the predominant daughter 
product.  Relatively low amounts of cDCE and VC appeared and then declined with each 
cycle of PCE consumption.  This pattern of activity was expected, since the SRS culture 
had been maintained on PCE and TCE as electron acceptors for several years. 
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 Beginning with the fourth addition of TCE, the rate of utilization started to slow 
down.  As with the PCE bottles, a problem with pH was suspected, since no attempt was 
made to neutralize the HCl released from TCE dechlorination.  On day 95, the pH of the 
bottles was found to be less than 6.0.  The pH was raised to 7.0 by adding 0.25 mL of 8 
M NaOH.  Lactate additions continued during this interval, and despite the pH being less 
than 6.0, methanogenesis continued.  This led to a considerable build up in pressure in the 
bottles.  To alleviate this, the bottles were vented on day 120.  This explains the vertical 
drop in methane, TCE, and ethene on day 120.  Thereafter, there was only a limited 
improvement in the rate of TCE reduction.  Apparently, the TCE culture was also unable 
to recover from the low pH episode.  During the full incubation period of 172 days, all of 
the TCE consumed was accounted for as ethene, with 0.32% of the lactate equivalents 
added consumed for reductive dechlorination (Table 4.1). 
 Figures 4.11-4.13 present the results for triplicate bottles that received cDCE as 
the sole chlorinated terminal electron acceptor.  There was no apparent lag in the onset of 
cDCE utilization.  The amount of cDCE added was increased, and the rate of utilization 
responded accordingly through day 45.  VC accumulated transiently during each cycle of 
cDCE dechlorination, although ethene was the predominant terminal product.  This 
provided the first direct evidence that the SRS culture is capable of using cDCE as a sole 
electron acceptor. 
 Beginning with the fourth addition of cDCE, the rate of utilization started to slow 
down.  As with the PCE and TCE bottles, a problem with pH was suspected, since no 
attempt was made to neutralize the HCl released from cDCE dechlorination.  On day 98, 
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the pH of the bottles was found to be in the range of 6.0-6.4.  The pH was raised to 7.0 by 
adding 0.12 mL of 8 M NaOH.  Lactate additions continued during this interval, and 
despite the pH being less than 6.4, methanogenesis continued.  This led to a considerable 
build up in pressure in the bottles.  To alleviate this, the bottles were vented on day 120.  
This explains the vertical drop in methane, cDCE, and ethene on day 120.  Thereafter, 
there was only a limited improvement in the rate of cDCE reduction.  Apparently, the 
culture was also unable to recover from the low pH episode.  During the full incubation 
period of 173 days, all of the cDCE consumed was accounted for as ethene and only 
0.42% of the lactate equivalents added was consumed for reductive dechlorination (Table 
4.1). 
 Figures 4.14-4.16 present the results for triplicate bottles that received tDCE as 
the sole chlorinated terminal electron acceptor.  Following a lag phase of approximately 
20 days, reduction of tDCE to ethene was observed.  The rate of dechlorination with the 
second addition of tDCE was initially similar but started to slow down considerably after 
day 79.  The reason for this is unclear.  It seemed unlikely to be a problem with pH 
because not as much tDCE had been dechlorinated compared to PCE, TCE and cDCE.  
However, on day 109, the pH was lower than desirable (i.e., 6.0-6.4), so 0.12 mL of 8 M 
NaOH was added to raise the pH to 7.0.  Lactate additions continued during this interval, 
and despite the pH being less than 6.4, methanogenesis continued.  This led to a 
considerable build up in pressure in the bottles.  To alleviate this, the bottles were vented 
on day 120.  This explains the vertical drop in methane, tDCE, and ethene on day 120.  
Thereafter, there was a short period of recovery, but then the rate of dechlorination 
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slowed again.  It became necessary to vent the bottles a second time on day 217.  
Following the fourth addition of tDCE to bottles #2 and #3, reductive dechlorination of 
tDCE was inconsistent (Figures 4.15 and 4.16).  During the full incubation period of 179 
days, less than half of the tDCE consumed was accounted for as ethene (Table 4.1), with 
the balance primarily VC; only 0.12% of the lactate equivalents added was consumed for 
reductive dechlorination (Table 4.1).  The tDCE results for Phase 1 suggested that tDCE 
is not used as a terminal electron acceptor by the SRS culture. 
 Results for the triplicate bottles that received 1,1-DCE as the sole chlorinated 
terminal electron acceptor are shown in Figures 4.17-4.19.  There was no apparent lag in 
the onset of 1,1-DCE utilization.  The amount of 1,1-DCE added was increased, and the 
rate of utilization responded accordingly through day 120.  VC accumulated transiently 
during each cycle of 1,1-DCE dechlorination, although ethene was the predominant 
terminal product.  This provided the first direct evidence that the SRS culture is capable 
of using 1,1-DCE as a sole terminal electron acceptor. 
 Beginning with the seventh addition of 1,1-DCE, the rate of utilization started to 
slow down.  As with the PCE, TCE, and cDCE bottles, a problem with pH was suspected, 
since no attempt was made to neutralize the HCl released from 1,1-DCE dechlorination.  
On day 109, the pH of the bottles was found to be less than 6.0.  The pH was raised to 
6.7-7.0 by adding 0.22-0.28 mL of 8 M NaOH.  Methanogenesis was very active in these 
bottles, leading to a considerable build up in pressure.  To alleviate this, the bottles were 
vented on days 120, 171, and 219 (bottle #1) or 232 (bottles #2 and #3).  This explains 
the vertical drop in methane, 1,1-DCE, and ethene on these days.  Three more additions 
 44 
of 1,1-DCE were made after the pH adjustment.  Unlike the situation with the other 
chlorinated ethenes described so far, the bottles that received 1,1-DCE improved in 
performance after pH adjustment and venting.  The final addition of 1,1-DCE was 
consumed as fast as or faster than any of the previous additions.  During the full 
incubation period of 252 days, all of the 1,1-DCE consumed was accounted for as ethene 
and only 0.42% of the lactate equivalents added was consumed for reductive 
dechlorination (Table 4.1). 
 Results for the triplicate bottles that received VC as the sole chlorinated terminal 
electron acceptor are shown in Figures 4.20-4.22.  There was no apparent lag in the onset 
of VC utilization.  The amount of VC added was increased, and the rate of utilization 
responded accordingly.  Ethene was the only product observed.  This provided the first 
direct evidence that the SRS culture is capable of using VC as a sole terminal electron 
acceptor.  On day 109, the pH of the bottles was found to be approximately 6.0.  The pH 
was raised to 6.7-7.0 by adding 0.13-0.16 mL of 8 M NaOH.  Methanogenesis was very 
active in these bottles, leading to a considerable build up in pressure.  To alleviate this, 
the bottles were vented on days 120, 171, and 199.  This explains the vertical drop in 
methane, VC, and ethene on these days.  Unlike the situation with the other chlorinated 
ethenes, the rate of VC utilization was quite consistent through the full incubation period, 
both before and after pH adjustment and venting.  All of the VC consumed was 
accounted for as ethene and only 0.56% of the lactate equivalents added was consumed 
for reductive dechlorination (Table 4.1). 
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 Figures 4.23-4.25 present the results for triplicate bottles that received 1,2-DCA 
as the sole chlorinated terminal electron acceptor.  Following a lag phase of 
approximately 18 days, reduction of 1,2-DCA to ethene began at a high rate.  Ethene was 
the only significant product observed; trace amounts of chloroethane and VC were 
detected occasionally.  After eight additions of approximately 7.5 µmol per bottle, the 
amount of 1,2-DCA added was increased to approximately 25 µmol per bottle (24 mg/L), 
and the rate of reduction increased correspondingly.  This provided the first direct 
evidence that the SRS culture is capable of using 1,2-DCA as a sole terminal electron 
acceptor.  The Phase 1 bottles that received 1,2-DCA were started after the bottles that 
received chlorinated ethenes, so the potential problem with pH control was known.  To 
avoid this issue, the pH was monitored periodically, and 8 M NaOH was added as needed 
to return the pH to neutral.  At no time was the pH allowed to drop below 6.4.  
Consequently, there was no interruption in the rate of 1,2-DCA utilization.  This is in 
contrast to what occurred with the PCE, TCE, cDCE, and 1,1-DCE bottles, in which the 
pH decreased below 6.0 and a high rate of reduction could not be restored even after 
adjusting the pH back to neutral.  Methanogenesis was very active in these bottles, 
leading to a considerable build up in pressure.  To alleviate this, the bottles were vented 
on days 62, 141, 158, and 170.  After 194-227 days of incubation, 94% of the 1,2-DCA 
consumed was recovered as ethene and only 0.44% of the lactate equivalents added was 
consumed for dihaloelimination (Table 4.1). 
 Results for the triplicate bottles that received EDB as the sole brominated terminal 
electron acceptor are shown in Figures 4.26-4.28.  Although this culture had never before 
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been exposed to a brominated organic compound, the lag phase prior to the onset of EDB 
utilization was only three days.  The amount of EDB added was gradually increased, and 
the rate of debromination responded accordingly.  Ethene was the only significant 
product observed; trace amounts of bromoethane and VB were detected occasionally.  
The highest amount of EDB added reached 24 µmol per bottle (22 mg/L).  This provided 
the first direct evidence that the SRS culture is capable of using EDB as a sole terminal 
electron acceptor.  As with the 1,2-DCA bottles, the Phase 1 bottles that received EDB 
were started after the bottles that received chlorinated ethenes, so the potential problem 
with pH control was known.  To avoid this issue, the pH was monitored periodically, and 
8 M NaOH was added as needed to return the pH to neutral.  At no time was the pH 
allowed to drop below 6.4.  Consequently, there was no interruption in the rate of EDB 
utilization.  Methanogenesis was very active in these bottles, leading to a considerable 
build up in pressure.  To alleviate this, the bottles were vented on days 62 and 134. After 
173 days of incubation, all of the EDB consumed was accounted for as ethene and only 
0.56% of the lactate equivalents added was consumed for dihaloelimination (Table 4.1). 
 Water controls were prepared for all of the volatile organic compounds that were 
quantified.  Average results for triplicate bottles that contained the chlorinated ethenes 
and ethene are shown in Figure 4.29.  Over 208 days of incubation, losses of PCE were 
highest, averaging 50%, although this was minor in comparison to the amount of PCE 
consumed in the live bottles (Figures 4.5-4.7).  Losses of TCE and VC averaged 20% and 
12%, respectively, and there was no loss of cDCE or ethene.  Average results for 
triplicate water controls that contained 1,2-DCA, EDB and VB indicate that only minor 
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losses occurred during 212 days of incubation (Figure 4.30), especially in comparison to 
the amount of 1,2-DCA and EDB consumed by the live bottles over a similar time period. 
 The pattern by which PCE, TCE, cDCE, 1,1-DCE, VC, 1,2-DCA and EDB were 
consumed during the Phase 1 experiment suggested that all are used as TEAs by the SRS 
culture.  Results for tDCE were inconclusive.  At the end of the incubation period, 
samples from all bottles were sent to Dr. Christopher Bagwell at SRS to quantify 
Dehalococcoides levels using qPCR.  Given the standard error in the measurement, it was 
difficult to discern a significant increase in Dehalococcoides between the start and end of 
the incubation period (data not shown).  A second experiment (referred to as Phase 2) 
was, therefore, performed to establish more definitively that consumption of the 
halogenated compounds is linked to an increase in the Dehalococcoides population.  A 
key difference between Phase 1 and Phase 2 was that Phase 2 was started with a much 
lower inoculum level (0.01%) in order to facilitate detection of a significant increase in 
the Dehalococcoides population. 
 Another major difference between Phases 1 and 2 was pH control.  Unlike Phase 
1, the pH in Phase 2 bottles was not allowed to deviate significantly from neutral.  This 
was accomplished by adding stoichiometric amounts of 8 M NaOH along with the 
halogenated compounds. 
4.2.2 Phase 2 
 The source of inoculum for the Phase 2 experiment is presented in Figure 3.1.  
Because the Phase 1 cultures with PCE, TCE, cDCE, and tDCE faltered as a result of 
problems with pH, the Phase 2 inoculum source for these compounds was the stock 
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enrichment culture maintained in 2.6 L glass bottles.  For 1,1-DCE, VC and 1,2-DCA, the 
sources of inocula were the respective Phase 1 bottles, since they performed consistently, 
and use of Phase 1 inocula offered the possibility of a reduced lag period, since the 
culture had already been acclimated to these compounds.  For EDB, all of the Phase 1 
culture was used to prepare a single large source of culture for a different project.  This 
EDB “mother bottle” was fed EDB repeatedly and performed similarly to the Phase 1 
bottles.  A 0.1% inoculum from the “EDB mother” was used for the Phase 2 EDB 
experiment.  Lastly, Phase 2 included an evaluation of VB as a terminal electron 
acceptor, even though it had not been tested during Phase 1.  The source of inoculum was 
the Phase 2 EDB bottles, once those had reached the targeted amount of Br- released (200 
µmol/bottle). 
 Results for the Phase 2 PCE bottles are shown in Figures 4.31-4.33.  Following a 
lag period of 19-31 days, all of the bottles started rapidly consuming PCE.  The longer 
lag period compared to Phase 1 (Figures 4.5-4.7) was not surprising, given the much 
lower inoculum level used for Phase 2.  cDCE accumulated and then started to decline, 
followed by a transient accumulation of VC.  A second addition of PCE was made on day 
67.  More VC accumulated, although ethene started to overtake VC.  By the time the 
third addition of PCE was consumed, ethene was the only significant daughter product, 
and this trend continued over subsequent additions.  pH problems did not arise (due to 
routine additions of NaOH and monitoring), and it was, therefore, possible to sustain a 
rapid rate of PCE dechlorination.  Following 112 days of incubation, 83% of the PCE 
consumed was attributable to ethene, and 0.74% of the lactate equivalents added was 
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consumed for reductive dechlorination (Table 4.2).  Methane output was approximately 
tenfold lower compared to the Phase 1 PCE bottles. 
 Results for the Phase 2 TCE bottles are shown in Figures 4.34-4.36.  Similarly to 
the PCE bottles, following a lag period of 19 days, all of the bottles started rapidly 
consuming TCE.  The longer lag period compared to Phase 1 (Figures 4.8-4.10) was not 
surprising, given the much lower inoculum level used for Phase 2.  cDCE accumulated 
and then started to decline, followed by a transient accumulation of VC.  A second 
addition of TCE was made on day 48.  VC and smaller amounts of cDCE accumulated 
transiently, but they were consumed and replaced by ethene as the major terminal 
product.  This trend continued over subsequent additions.  pH problems did not arise, and 
it was, therefore, possible to sustain a rapid rate of TCE dechlorination.  Following 103 
days of incubation, 91% of the TCE consumed was attributable to ethene, and 0.79% of 
the lactate equivalents added was consumed for reductive dechlorination (Table 4.2).  
Methane output was approximately eightfold lower compared to the Phase 1 TCE bottles. 
 Results for the Phase 2 cDCE bottles are shown in Figures 4.37-4.39.  Following 
a lag period of 31 days, all of the bottles started rapidly consuming cDCE.  The longer 
lag period compared to Phase 1 (Figures 4.11-4.13) was not surprising, given the much 
lower inoculum level used for Phase 2.  VC accumulated and then declined as ethene was 
produced.  A second addition of cDCE was made on day 54.  VC and ethene were 
produced simultaneously as the cDCE was consumed. 
 On the fourth addition of cDCE, dechlorination began to slow down, and by the 
fifth addition, dechlorination had slowed significantly.  pH problems did not appear to be 
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the cause of the decrease in dechlorination activity, as the pH was not allowed to drop 
below 6.7 during the entire incubation.  The only difference in the fourth and fifth 
additions as compared to the previous additions was the manner in which cDCE was 
added to the bottles.  cDCE was added as saturated water prior to the fourth addition, at 
which time cDCE was added as a neat compound.  The same neat cDCE was used to 
make the saturated water; therefore, the decrease in activity did not appear to be caused 
by inhibitors in the neat cDCE (99% purity).  The Phase 1 cDCE bottles never received 
neat cDCE, so it is unclear if this was the cause of the inhibition.  Bottle #1 eventually 
consumed all of the cDCE from the fifth addition, as well as the VC produced during the 
cycle, to produce ethene as the primary terminal product.  Bottles #2 and #3 did not 
completely consume the cDCE and VC from the fifth addition but were expected to 
follow the same trend as bottle #1.  Following 174 days of incubation, 80% of the cDCE 
consumed was attributable to ethene and 6% to VC; 0.58% of the lactate equivalents 
added was consumed for reductive dechlorination (Table 4.2).  Methane output was 
approximately half the output of the Phase 1 cDCE bottles. 
 Results for the Phase 2 tDCE bottles are shown in Figures 4.40-4.42.  Following a 
lag period of 31 days, all of the bottles started rapidly consuming tDCE.  The longer lag 
period compared to Phase 1 (Figures 4.14-4.16) was not surprising, given the much lower 
inoculum level used for Phase 2.  VC accumulated transiently and then declined as ethene 
was produced.  A second addition of tDCE was made on day 54.  The same trend 
continued over subsequent additions with ethene as the major terminal product.  
Although results from the Phase 1 tDCE bottles were inconclusive, the Phase 2 results 
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provided the first direct evidence that the SRS culture is also capable of using tDCE as a 
sole terminal electron acceptor.  pH problems did not arise, and it was, therefore, possible 
to sustain a rapid rate of tDCE dechlorination.  Following 127 days of incubation, 93% of 
the tDCE consumed was attributable to ethene, and 0.66% of the lactate equivalents 
added was consumed for reductive dechlorination (Table 4.2).  Methane output was 
approximately twenty times lower compared to the Phase 1 tDCE bottles. 
 Results for the Phase 2 1,1-DCE bottles are shown in Figures 4.43-4.45.  
Following a lag period of 34-48 days, all of the bottles started rapidly consuming 1,1-
DCE.  The longer lag period compared to Phase 1 (Figures 4.17-4.19) was not surprising, 
given the much lower inoculum level used for Phase 2.  VC accumulated transiently and 
then declined as ethene was produced.  A second addition of 1,1-DCE was made on day 
57.  VC and ethene were produced simultaneously with the major terminal product being 
ethene.  The same trend continued over subsequent additions.  pH problems did not arise, 
and it was, therefore, possible to sustain a rapid rate of 1,1-DCE dechlorination.  
Following 138 days of incubation, 72% of the 1,1-DCE consumed was attributable to 
ethene, and 0.60% of the lactate equivalents added was consumed for reductive 
dechlorination (Table 4.2).  Methane output was more than tenfold lower compared to the 
Phase 1 1,1-DCE bottles. 
 Results for the Phase 2 VC bottles are shown in Figures 4.46-4.48.  Following a 
lag period of 34-48 days, all of the bottles started rapidly consuming VC.  The longer lag 
period compared to Phase 1 (Figures 4.20-4.22) was not surprising, given the much lower 
inoculum level used for Phase 2.  Ethene was the only product observed.  A second 
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addition of VC was made on day 57.  pH problems did not arise, and it was, therefore, 
possible to sustain a rapid rate of VC dechlorination.  Following 138 days of incubation, 
91% of the VC consumed was attributable to ethene, and 0.79% of the lactate equivalents 
added was consumed for reductive dechlorination (Table 4.2).  Methane output was six 
times lower than the methane production in the Phase 1 VC bottles. 
 Results for the Phase 2 1,2-DCA bottles are shown in Figures 4.49-4.51.  
Following a lag period of 36-48 days, all of the bottles started rapidly consuming 1,2-
DCA.  The longer lag period compared to Phase 1 (Figures 4.23-4.25) was not surprising, 
given the much lower inoculum level used for Phase 2.  Ethene was the only significant 
product observed; trace amounts of VC were detected occasionally.  A second addition of 
1,2-DCA was made on day 60, and the same trend continued over subsequent additions.  
pH problems did not arise, and it was, therefore, possible to sustain a rapid rate of 1,2-
DCA dechlorination.  Following 105 days of incubation, 94% of the 1,2-DCA consumed 
was attributable to ethene, and 0.41% of the lactate equivalents added was consumed for 
dihaloelimination (Table 4.2).  Methane output was threefold less than the Phase 1 1,2-
DCA bottles. 
 Results for the Phase 2 EDB bottles are shown in Figures 4.52-4.54.  Following a 
lag period of 20-28 days, all of the bottles started rapidly consuming EDB.  The longer 
lag period compared to Phase 1 (Figures 4.26-4.28) was not surprising, given the much 
lower inoculum level used for Phase 2.  Ethene was the only significant product 
observed; trace amounts of bromoethane were detected occasionally.  A second addition 
of EDB was made on day 28 (bottle #3) or day 36 (bottles #1 and #2), and the same trend 
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continued over subsequent additions.  EDB was consumed the fastest of all tested 
compounds.  pH problems did not arise, and it was, therefore, possible to sustain a rapid 
rate of EDB debromination.  Following 90 days of incubation, 84% of the EDB 
consumed was attributable to ethene, and 0.60% of the lactate equivalents added was 
consumed for dihaloelimination (Table 4.2).  Methane output was more than tenfold 
lower than the Phase 1 EDB bottles. 
 Results for the Phase 2 triplicate bottles that received VB as the sole brominated 
terminal electron acceptor are shown in Figures 4.55-4.57.  Following a lag period of 26 
days, all of the bottles started rapidly consuming VB.  The amount of VB added was 
gradually increased, and the rate of debromination responded accordingly.  Ethene was 
the only significant product observed.  The highest amount of VB added reached 62 µmol 
per bottle (51 mg/L).  This provided the first direct evidence that the SRS culture is 
capable of using VB as a sole terminal electron acceptor.  As these bottles were started 
after Phase 1, the potential problem with pH control was known.  To avoid this, the pH 
was monitored at every VB addition, and 8 M NaOH was added along with VB to return 
the pH to neutral.  At no time was the pH allowed to drop below 6.6.  Consequently, there 
was no interruption in the rate of VB utilization.  It was, therefore, possible to sustain a 
rapid rate of VB debromination.  Following 122 days of incubation, 95% of the VB 
consumed was attributable to ethene, and 0.81% of the lactate equivalents added was 
consumed for reductive debromination (Table 4.2).  Methanogenesis occurred during the 
incubation but methane did not reach high enough levels to require venting. 
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 It is apparent from the consumption patterns that all of the halogenated alkenes 
and alkanes tested are used rapidly by the SRS culture, suggesting that they are used as 
terminal electron acceptors.  A more robust indication of use as a terminal electron 
acceptor is a direct association between dehalogenation and an increase in 
Dehalococcoides.  The levels of Dehalococcoides in all treatments were quantified at the 
start and end of the Phase 2 incubation period by Dr. Christopher Bagwell, using qPCR.  
Results are shown in Table 4.3.  All treatments consumed enough of the test compound to 
release at least 200 µmol of Cl- or Br- per bottle.  By comparing the initial and final 
Dehalococcoides concentrations, it is readily apparent that there was an increase in 
Dehalococcoides of at least 2 to 3 orders of magnitude, i.e., the concentrations increased 
from an initial concentration of approximately 106 gene copies per mL to a final 
concentration of 108-109 genes copies per mL.  For 1,1-DCE, VC, EDB, and VB, the 
initial concentrations were even lower; recall that the source of inoculum for these 
treatments was not the stock enrichment culture (Figure 3.1).  Nevertheless, these 
treatments finished with similar concentrations of Dehalococcoides compared to the other 
compounds (i.e., 108-109 genes per mL).  The exception was EDB, which had a 
considerably lower final concentration of Dehalococcoides. 
 Based on the net increase in Dehalococcoides and the average release of chloride 
or bromide (calculated based on the amount of parent compound consumed and daughter 
products formed, rather than direct measurement of the anions), yield values were 
calculated in terms of gene copies per µmol of Cl- or Br- released.  Yields ranged from 
7.9x107 for VC to 1.8x109 gene copies per µmol of Cl- for 1,2-DCA.  The only outlier 
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was for EDB, which had an unexpectedly low yield of 6.8x105 gene copies per µmol of 
Br-.  A comparison of these values to yields reported for other cultures will be presented 
in the Discussion. 
4.3 Reductive Dechlorination of Chlorinated Benzenes 
 Results for the triplicate bottles that received HCB as the sole chlorinated terminal 
electron acceptor are shown in Figures 4.58-4.60.  After 19 days of incubation, almost all 
of the HCB was consumed.  PeCB and 1,2,4,5-TeCB were detected, which indicated that 
HCB was dechlorinated to PeCB and 1,2,4,5-TeCB.  However, the levels of PeCB and 
1,2,4,5-TeCB were much higher than the molar amount of HCB that was added to the 
bottles.  The same amount of HCB was added during repeat additions (Table 3.1).  Rapid 
consumption of HCB was observed with formation of PeCB and 1,2,4,5-TeCB.  On day 
27, 1,2,4-TCB was also detected as a dechlorination product.  1,2,4-TCB was present in 
even larger amounts than the PeCB or 1,2,4,5-TeCB, which was also inconsistent with 
the molar amount of HCB added to the bottles.  The percent recoveries of HCB 
dechlorination products are shown in Table 4.4, as well as the ratio of electron 
equivalents used for dechlorination to the electron equivalents of lactate added.  To 
further support disappearance of HCB as a result of biotic dechlorination, the autoclaved 
controls (Figure 4.61) showed no loss of HCB over 36 days of incubation.  Regardless of 
the poor mass balance for the daughter products, the observed disappearance of HCB and 
appearance of 1,2,4-TCB suggests that the SRS culture may be capable of using HCB as 
a sole chlorinated electron acceptor.  No dichlorobenzene isomers or CB were detected 
over the course of incubation.  However, the lack of DCBs and CB is insufficient 
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evidence to conclude that 1,2,4-TCB cannot be reductively dechlorinated by the SRS 
culture.  The amounts of DCBs and CB that could have formed based on the total amount 
of HCB consumed (i.e., an average of 9.31x103 µmol/bottle) were too low to be detected.  
Results for treatments started with DCBs and CB at higher levels are presented below.  
For the triplicate bottles with HCB added, methane production was very active, which 
indicates that the concentrations of HCB used, and its subsequent daughter products, 
were not inhibitory (Table 4.4). 
 Results for the triplicate bottles that received PeCB as the sole chlorinated 
terminal electron acceptor are shown in Figures 4.62-4.64.  After 20 days of incubation, 
all of the PeCB was consumed.  1,2,4-TCB and 1,3,5-TCB were detected as 
dechlorination products; only a trace amount of 1,2,4,5-TeCB was detected.  The 
presence of 1,3,5-TCB indicated that 1,2,3,5-TeCB must also be a dechlorination 
product, as 1,3,5-TCB is only formed from dechlorination of 1,2,3,5-TeCB; however, 
both 1,2,3,5-TeCB and 1,2,4,5-TeCB co-elute on the column and could not be 
distinguished as two separate compounds.  Therefore, it was assumed that the TeCB 
isomers eluting at 6.3 min was all 1,2,4,5-TeCB.  The percent recoveries of PeCB 
dechlorination products are shown in Table 4.4, as well as the ratio of electron 
equivalents used for dechlorination to the electron equivalents of lactate added.  
Subsequent additions of PeCB were made at the same concentrations initially added to 
the bottles (Table 3.1).  Initially, the bottles were only being analyzed on the ECD.  On 
days 67 (bottles #1 and #2) and 82 (bottle #3), the bottles were analyzed for the first time 
using the FID, and 1,2-DCB and 1,4-DCB were also detected as daughter products.  This 
 57 
explains why no data for 1,2-DCB or 1,4-DCB is shown on Figures 4.62-4.64 prior to 
these days.  No 1,3-DCB or CB were detected over the course of incubation.  These 
results suggested that the SRS culture may be capable of using PeCB as a sole electron 
acceptor.  There was an 85% recovery of the PeCB as 1,2,4-TCB, 1,3,5-TCB, 1,2-DCB, 
and 1,4-DCB.  For the triplicate bottles with PeCB added, methane production was very 
active, which indicates that the concentrations of PeCB used, and its subsequent daughter 
products, were not inhibitory (Table 4.4). 
 Results for the triplicate bottles that received 1,2,4,5-TeCB as the sole chlorinated 
terminal electron acceptor are shown in Figures 4.65-4.67.  After 20 days of incubation, 
all of the 1,2,4,5-TeCB was consumed.  1,2,4-TCB was the only dechlorination product 
detected.  The percent recoveries of 1,2,4,5-TeCB dechlorination products are shown in 
Table 4.4, as well as the ratio of electron equivalents used for dechlorination to the 
electron equivalents of lactate added.  Subsequent additions of 1,2,4,5-TeCB were made 
at the same concentrations initially added to the bottles (Table 3.1) and rapid 
consumption continued.  Like the PeCB bottles, the 1,2,4,5-TeCB bottles were not 
analyzed on the FID prior to day 67.  On day 67, the bottles were analyzed using the FID 
for the first time, and 1,2-DCB and 1,4-DCB were also detected as daughter products.  
This explains the absence of data for 1,2-DCB and 1,4-DCB on Figures 4.65-4.67 prior to 
day 67.  1,3-DCB and CB were not detected over the course of incubation.  There was a 
91% recovery of the PeCB as 1,2,4-TCB, 1,3,5-TCB, 1,2-DCB, and 1,4-DCB.  These 
results suggested that the SRS culture may be capable of using PeCB as a sole electron 
acceptor.  For the triplicate bottles with 1,2,4,5-TeCB added, methane production was 
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very active, which indicates that the concentrations of 1,2,4,5-TeCB used, and its 
subsequent daughter products, were not inhibitory (Table 4.4). 
 Results for the triplicate bottles that received 1,2,4-TCB as the sole chlorinated 
terminal electron acceptor are shown in Figures 4.68-4.70.  By day 20, there was a 
significant decrease in the concentration of 1,2,4-TCB, but no significant increase in 
daughter products.  This may have been caused by an error in the initial measurements or 
abiotic losses.  After day 20, further decreases in 1,2,4-TCB were accompanied by an 
increase in 1,2-DCB and 1,4-DCB.  A trace amount of CB also accumulated, which was 
the first detection of CB as an end product of chlorinated benzene dechlorination by the 
SRS enrichment culture.  On day 82, a second addition of 1,2,4-TCB was consumed with 
no apparent lag.  There was a 58% recovery of the 1,2,4-TCB as 1,2-DCB, 1,4-DCB, and 
CB.  The average percent recoveries of 1,2,4-TCB dechlorination products are shown in 
Table 4.4, as well as the ratio of electron equivalents used for dechlorination to the 
electron equivalents of lactate added.  These results suggested that the SRS culture may 
be capable of using 1,2,4-TCB as a sole electron acceptor.  For the triplicate bottles with 
1,2,4-TCB added, methane production was very active, which indicates that the 
concentrations of 1,2,4-TCB used, and its subsequent daughter products, were not 
inhibitory (Table 4.4). 
 Results for the triplicate bottles that received 1,2-DCB as the sole chlorinated 
terminal electron acceptor are shown in Figures 4.71-4.73.  After 18 days of incubation, 
the amount of 1,2-DCB present decreased, although CB was not detected as a 
dechlorination product.  This may have been caused by an error in the initial 
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measurement or abiotic losses.  Thereafter, the concentration of 1,2-DCB remained 
constant, with no formation of CB or benzene.  These results demonstrated that the SRS 
enrichment culture does not utilize 1,2-DCB as an electron acceptor.  Methane production 
was active in these bottles, although no dechlorination occurred (Table 4.4). 
 Results for the triplicate bottles that received 1,3-DCB as the sole chlorinated 
terminal electron acceptor are shown in Figures 4.74-4.76.  After 18 days of incubation, 
there was a decrease in the amount of 1,3-DCB present, although CB was not detected as 
a dechlorination product.  This may have been caused by an error in the initial 
measurements or abiotic losses.  Thereafter, the concentration of 1,3-DCB remained 
approximately constant, with no formation of CB or benzene.  These results demonstrated 
that the SRS enrichment culture does not utilize 1,3-DCB as an electron acceptor.  
Methane production was active in these bottles, although no dechlorination occurred 
(Table 4.4). 
 Results for the triplicate bottles that received 1,4-DCB as the sole chlorinated 
terminal electron acceptor are shown in Figures 4.77-4.79.  After 18 days of incubation, 
there was an approximately 20% decrease in 1,4-DCB, although CB was not detected as a 
dechlorination product.  After day 18, the concentration of 1,4-DCB fluctuated, with no 
apparent decreasing trend.  These results demonstrated that the SRS enrichment culture 
does not utilize 1,4-DCB as an electron acceptor.  Methane production was active in these 
bottles, although no dechlorination occurred (Table 4.4). 
 Results for the triplicate bottles that received CB as the sole chlorinated terminal 
electron acceptor are shown in Figures 4.80-4.82.  After 18 days of incubation, there was 
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a notable drop in CB, although benzene was not detected as a dechlorination product.  
After day 18, the concentration of CB remained approximately constant, with no 
formation of benzene.  These results demonstrated that the SRS enrichment culture does 
not utilize CB as an electron acceptor.  Methane production was active in these bottles 
although, no dechlorination occurred (Table 4.4). 
 In summary, HCB, PeCB, 1,2,4,5-TeCB, and 1,2,4-TCB were reductively 
dechlorinated at increasing rates over time, a pattern of consumption that suggests these 
compounds may be utilized as TEAs by the SRS enrichment culture.  The results for 1,2-
DCB, 1,3-DCB, 1,4-DCB, and CB demonstrate that the SRS enrichment culture does not 
reductively dechlorinate these compounds, and therefore, they are not useable as TEAs.  
The large decreases in the initial concentrations of 1,2-DCB, 1,3-DCB, and CB were 
similar to the decreases in the concentrations of these compounds in the WCs (Figures 
4.83-4.84).  As mentioned above, this may be due to an error in the initial measurements 
or abiotic losses.  The percent losses of all of the compounds from the WCs and live 
bottles were similar and are summarized in Table 4.5. 
4.4 Evaluation of Potential Pathogens in the SRS Enrichment Culture  
4.4.1 Growth in TSB  
 A preliminary test for the presence of pathogens in the SRS enrichment culture 
was conducted by determining if the culture grows at the temperature of the human body 
(37°C) in a rich medium (TSB) under aerobic conditions.  Growth was evaluated based 
on an increase in turbidity.  The positive control, inoculated with activated sludge from 
the City of Clemson wastewater treatment plant, performed as expected, i.e., the medium 
 61 
became turbid within 24 hours of incubation.  The negative control, inoculated with 
sterile water, also performed as expected, i.e., there was no increase in turbidity after 48 
hours of incubation.  This indicated that the aseptic technique used to prepare the 
experiment was adequate.  The flasks inoculated with the SRS culture became turbid 
within 24 hours, indicating that the culture does contain microbes that are capable of 
growing aerobically at 37°C.  Had this result been negative, it would have indicated that 
human pathogens are very likely absent from the SRS culture.  The fact that the result 
with TSB was positive did not demonstrate the presence of pathogens; however, it did 
suggest that further testing was necessary. 
4.4.2 Evaluation of Total Coliforms and E. coli  
 A subsequent experiment was conducted to determine the presence or absence of 
coliforms (i.e., without quantification) and E. coli in the SRS enrichment culture.  Both 
positive controls set up with Colilert® and Readycult®, inoculated with raw sewage from 
the City of Clemson wastewater treatment plant, performed as expected.  All of the 
positive controls grown in Colilert® turned yellow and those grown in the Readycult® 
turned blue/green within 24 hours of incubation.  These color changes indicated the 
presence of coliforms.  Positive samples were then illuminated with a 365 nm UV light, 
and all of them fluoresced, indicating the presence of E. coli. 
 One set of negative controls were inoculated with sterile water and performed as 
expected.  The Colilert® samples remained clear and the Readycult® samples turned 
yellow after 24 hours of incubation.  A second set of negative controls, using only 
Colilert® media, were inoculated with autoclaved sewage.  These also performed as 
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expected; i.e., the samples remained clear.  These results indicated that the aseptic 
technique used to prepare the experiment was adequate.   
 The SRS culture tested positive for coliforms with both types of media.  All of 
these samples, however, tested negative for E. coli. 
4.5 Evaluation of Chlorinated Ethene Inhibition by 1,1,1-TCA 
 As described in Section 3.5, a preliminary inhibition experiment was performed 
with a high concentration of 1,1,1-TCA (300 µM), modeled after a previous study by 
Grostern and Edwards (23).  Based on the results of this first phase, a second set of 
experiments was performed at lower concentrations of 1,1,1-TCA as well as a more 
dilute initial culture, to better simulate conditions that may exist during bioaugmentation.  
The results for the Phase 1 experiment are presented first, followed by Phase 2. 
4.5.1 Phase 1 
 Results for the triplicate bottles provided with 300 µM TCE (30.11 µmol/bottle) 
are shown in Figures 4.85-4.87.  In the absence of 1,1,1-TCA, TCE dechlorination 
occurred rapidly, partly due to the use of undiluted SRS enrichment culture.  After only 
one day of incubation, less than five µmol TCE remained in the bottles, and a 
stoichiometric increase in ethene was observed.  Complete consumption of TCE was 
observed when the next measurement was made on day three, although it is likely that 
dechlorination was completed even earlier.  Only transient amounts of cDCE and VC 
were detected during the first three days.  Methane production was immediate and 
continued through day 12. 
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 Figures 4.88-4.90 present the results for the triplicate bottles that were amended 
with 300 µM TCE + 300 µM 1,1,1-TCA (30.11 µmol/bottle TCE and 48.25 µmol/bottle 
1,1,1-TCA).  Although there was no apparent lag in dechlorination of TCE, the rate of 
consumption was slower than in the TCE-only bottles.  The presence of 1,1,1-TCA 
approximately doubled the average time required for TCE dechlorination (Figure 4.91).  
The maximum amount of cDCE that accumulated also increased in the presence of 1,1,1-
TCA (Figure 4.92).  Most significantly, the presence of 1,1,1-TCA severely inhibited 
reductive dechlorination of VC to ethene (Figure 4.93).  A decrease in VC and 
stoichiometric increase in ethene occurred on day 7 and continued until VC and ethene 
stabilized at approximately 10 and 23 µmol per bottle, respectively, on day 18.  The 
bottles were monitored for 19 more days, and VC reduction to ethene slowed 
considerably (Figure 4.94).  Methane production was completely inhibited by the 
presence of 1,1,1-TCA (Figure 4.95).  The amount of 1,1,1-TCA present decreased by 
approximately 35% during the first seven days of incubation and then remained relatively 
constant for the duration of the experiment.  No significant increase in 1,1-DCA, CA, or 
ethane was detected to account for this decrease.  It is not yet clear what may have caused 
the initial decrease in 1,1,1-TCA. 
4.5.2 Phase 2 
 Results for the triplicate bottles provided with 31 µM TCE (2.2 µmol/bottle) are 
shown in Figures 4.96-4.98.  There was no apparent lag in the onset of TCE 
dechlorination.  TCE was completely consumed by day 15 (bottles #1 and #3) or day 22 
(bottle #2).  Small amounts of cDCE and VC accumulated transiently, but all of the TCE 
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was accounted for as ethene after 26 days of incubation.  Due to the much lower 
inoculum level used for the Phase 2 experiment, TCE was consumed approximately six 
times slower than in the Phase 1 TCE-only bottles, even though the initial TCE 
concentration was an order of magnitude lower with Phase 2. 
 Results for the triplicate bottles provided with 31 µM TCE + 0.7 µM 1,1,1-TCA 
(2.3 µmol/bottle TCE and 0.1 µmol/bottle 1,1,1-TCA) are shown in Figures 4.99-4.101.  
As with the TCE-only treatment, there was no apparent lag in the onset of TCE 
dechlorination.  TCE was completely consumed by day 15 (bottles #1 and #2) or day 22 
(bottle #3).  Small amounts of cDCE and VC accumulated transiently, but all of the TCE 
was accounted for as ethene after 27 days of incubation.  These results indicated that 0.7 
µM 1,1,1-TCA is not an inhibitory concentration for the SRS culture, at least under the 
conditions of this experiment.  There was no significant decrease in the initial 
concentration of 1,1,1-TCA, and 1,1-DCA, CA, and ethane were not detected as daughter 
products. 
 Results for the triplicate bottles provided with 31 µM TCE + 3.6 µM 1,1,1-TCA 
(2.2 µmol/bottle TCE and 0.5 µmol/bottle 1,1,1-TCA) are shown in Figures 4.102-4.104.  
TCE dechlorination began after a lag of 13 days in bottles #1 and #2; however, TCE 
dechlorination started immediately in bottle #3.  Despite the lag in bottles #1 and #2, 
TCE was completely consumed by day 22 in all bottles.  Bottle #3 performed similarly to 
the first two treatments, with only transient accumulation of small amounts of cDCE and 
VC; all TCE was accounted for as ethene by day 22.  cDCE and VC accumulated to 
higher amounts in bottles #1 and #2, reaching a maximum on day 22.  After day 22, 
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cDCE and VC declined and ethene production increased.  These results indicated that 3.6 
µM 1,1,1-TCA slows, but does not prevent, the complete dechlorination of TCE to ethene 
by the SRS enrichment culture.  There was no significant decrease in the initial 
concentration of 1,1,1-TCA, and 1,1-DCA, CA, and ethane were not detected as daughter 
products. 
 Results for the triplicate bottles amended with 31 µM TCE + 18 µM 1,1,1-TCA 
(2.1 µmol/bottle TCE and 2.5 µmol/bottle 1,1,1-TCA) are shown in Figures 4.105-4.107.  
There was no apparent lag in the onset of TCE dechlorination.  TCE was completely 
consumed by day 27 or day 36 for bottles #1 and #2, respectively.  After 42 days of 
incubation, 0.22 µmol/bottle TCE remained in bottle #3.  cDCE and VC increased as 
TCE declined, along with some ethene production.  As cDCE declined, VC and ethene 
increased further.  On day 42, a slight decrease in VC was observed in bottles #1 and #2, 
but it was unclear whether the VC would be completely consumed or if it would stall.  
These results indicated that 18 µM 1,1,1-TCA slows dechlorination of TCE and may 
permanently inhibit conversion of VC to ethene.  There was no significant decrease in the 
initial concentration of 1,1,1-TCA, and 1,1-DCA, CA, and ethane were not detected as 
daughter products. 
 Figure 4.108 summarizes the effect of 1,1,1-TCA at all levels tested during Phase 
2 on TCE reductive dechlorination.  The lowest concentration of 1,1,1-TCA (0.7 µM) did 
not appear to be inhibitory.  However, higher concentrations of 1,1,1-TCA (3.6 and 18 
µM) slowed the rate of TCE reduction.  At a 1,1,1-TCA concentration of 3.6 µM, there 
was an increase in the maximum amount of cDCE that accumulated and the length of 
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time it took to reach the maximum (Figure 4.109).  At 18 µM 1,1,1-TCA, reduction of 
cDCE appeared to stall after reaching approximately 0.25 µmol/bottle but after 36 days, 
decreased to less than 0.1 µmol/bottle.  Increasing concentrations of 1,1,1-TCA increased 
the maximum amount of VC that accumulated (Figure 4.110).  Most importantly, 
increasing concentrations of 1,1,1-TCA slowed the rate of ethene formation and, at 18 
µM 1,1,1-TCA, prevented complete reduction even after 42 days of incubation (Figure 
4.111).  At the concentrations tested during Phase 2, 1,1,1-TCA inhibited methanogenesis 
(Figure 4.112), although to a lesser extent than during Phase 1.  A decrease in 1,1,1-TCA 
was observed in all treatments amended with 1,1,1-TCA as well as the WCs (Figure 
4.113).  A 21% decrease in 1,1,1-TCA occurred in the WCs which was similar to the 18 
µM 1,1,1-TCA treatment, which decreased by 27%.  The other treatments lost an average 
of 34%-48% of the 1,1,1-TCA added to the bottles. 
4.6 Microcosm Evaluation of EOS® as an Electron Donor 
 During the microcosm experiment to evaluate EOS as an electron donor, all of the 
treatments reached a low redox level by day eight, based on a change in the color of the 
resazurin added to the groundwater.  The treatment with lactate added and no 
bioaugmentation was used as a control. 
 Results for the lactate-only microcosms are presented in Figures 4.114-4.116.  As 
expected, no dechlorination of PCE or TCE was observed, and there was no formation of 
methane.  The fluctuation in TCE levels over the first several weeks may be attributable 
to abiotic processes such as adsorption.  The average losses of PCE and TCE during 85 
days of incubation were 23% and 15%, respectively. 
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 Results for the triplicate microcosms amended with lactate and bioaugmented 
with the SRS enrichment culture on day 10 are presented in Figures 4.117-4.119.  After a 
lag of 18 days following bioaugmentation, consumption of PCE and TCE started.  cDCE 
and VC accumulated during PCE and TCE dechlorination.  cDCE increased to a 
maximum on day 49 and then declined as VC and ethene increased.  Methanogenesis was 
minimal, with an average accumulation of 1.4 µmol/bottle. 
 Results for the triplicate microcosms amended with EOS® 450 and bioaugmented 
with the SRS enrichment culture on day 10 are presented in Figures 4.120-4.122.  After a 
lag of 18 days following bioaugmentation, rapid consumption of PCE and TCE started 
and was complete by day 42.  cDCE accumulated, along with lesser amounts of VC, 
followed by an increasing rate of ethene formation.  More methane was produced in this 
treatment than in the lactate-fed microcosms, averaging 8.5 µmol/bottle. 
 Results for the triplicate microcosms amended with EOS® 598 and bioaugmented 
with the SRS enrichment culture on day 10 are presented in Figures 4.123-4.125.  After a 
lag of 18 days following bioaugmentation, rapid consumption of PCE and TCE started 
and was complete by days 42-65.  cDCE accumulated, along with lesser amounts of VC, 
followed by an increasing rate of ethene formation.  An average of 8.5 µmol/bottle of 
methane was produced in this treatment, which was comparable to the EOS® 450 
treatment. 
 Results for the triplicate microcosms amended with EOS® 598B42 and 
bioaugmented with the SRS enrichment culture on day 10 are presented in Figures 4.126-
4.128.  After a lag of 18 days following bioaugmentation, consumption of PCE and TCE 
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started.  cDCE accumulated, along with lesser amounts of VC, followed by an increasing 
rate of ethene formation.  An average of 2.8 µmol/bottle of methane was produced in this 
treatment, which was approximately four times lower than in the EOS® 450 and EOS® 
598 treatments. 
 Results for the triplicate microcosms amended with EOS® 598B42 + EOS® 
Vitamin B12 solution and bioaugmented with the SRS enrichment culture on day 10 are 
presented in Figures 4.129-4.131.  After a lag of 17-26 days following bioaugmentation, 
consumption of PCE and TCE started and was complete after 43-65 days of incubation.  
cDCE, VC, and ethene increased simultaneously in microcosms #1 and #2, followed by a 
decrease in cDCE and VC and further increase in ethene.  Microcosm #3 accumulated 
more cDCE initially, followed by an increase in VC, and then ethene.  An average of 7.5 
µmol/bottle of methane was produced in this treatment, which was similar to the EOS® 
450 and EOS® 598 treatments. 
 A comparison of the microcosm treatments shows that the rate of PCE 
dechlorination was approximately equivalent with all of the EOS® products, and 
somewhat slower with lactate (Figure 4.132).  A similar trend occurred with TCE, 
although the rates for EOS® 450 and EOS® 598 were slightly faster than for EOS® 
598B42 and EOS® 598B42 + EOS® Vitamin B12 solution (Figure 4.133).  Larger 
amounts of cDCE and VC accumulated and disappeared more rapidly when EOS® 450 
and EOS® 598 were used as electron donors (Figures 4.134-4.135).  Most importantly, 
ethene production was initially faster in microcosms amended with EOS® 450 and EOS® 
598, although the final level of ethene was reached at approximately the same time in all 
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EOS®-amended treatments (Figures 4.136). The addition of the Vitamin B12 solution did 
not appear to greatly improve the effectiveness of the EOS® 598B42.  Ethene 
accumulation was notably slower with lactate, in spite of the fact that the enrichment 
culture is routinely grown with lactate as the electron donor. 
4.7 Oxygen Tolerance Experiment 
 Results for the preliminary oxygen tolerance experiment conducted with single 
bottles are not included in this section but are shown in Figures E.1-E.3 (Appendix E).  In 
order to evaluate the effect of exposing the SRS enrichment culture to air, a treatment 
was included with no air exposure, serving as a positive control.  Results for PCE and 
TCE dechlorination were as expected (Figures 4.137-4.139).  Consumption of PCE and 
TCE began immediately without a lag.  On day six, small amounts of cDCE and VC were 
detected.  Most of the PCE and TCE consumed was converted directly to ethene.  
Stoichiometric reduction of the PCE and TCE to ethene was complete by day 13.  By day 
44, an average of 5.0% of the electron equivalents of lactate added was recovered as 
methane. 
 Results for the triplicate bottles that were quiescently exposed to air for 24 hours 
are shown in Figures 4.140-4.142.  Reductive dechlorination of the PCE and TCE in 
bottles #1 and #2 started without a lag but was comparatively slow, with accumulation of 
cDCE by day 20.  In bottle #3, there was a definite lag period prior to the onset of PCE 
and TCE dechlorination.  By day 27, the PCE and TCE were consumed in all three 
bottles.  This was accompanied by a stoichiometric increase in cDCE.  On day 44, 
disappearance of the majority of cDCE and a concurrent increase in VC and ethene was 
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observed, followed by stoichiometric accumulation of ethene.  This indicated that the 
culture’s ability to completely dechlorinate PCE and TCE is slowed but not completely 
inhibited by exposure of the headspace to air for at least 24 hours.  There was a lag in 
methane production of six to 13 days, after which methane increased steadily, although 
not at the same rate as in the control bottles that were not exposed to the air. 
 The percentage of oxygen in the headspace of the bottles was also monitored and 
decreased by approximately half by day two (Figure 4.143).  The next time an oxygen 
measurement was made, on day seven, no oxygen was detected in bottles #2 and #3, 
suggesting it may have been consumed even sooner.  A small amount of oxygen 
remained in bottle #1 but was no longer detectable by day nine. 
 While the bottles were exposed to the air, the liquid turned pink and the top layer 
of settled iron sulfides turned from black to a gray color, indicating the media had 
become oxidized.  After 24 hours, the bottles were sealed and mixed, at which point all of 
the sulfides became a grayish color.  By day seven, the media had become clear and the 
iron sulfides returned to a black color, indicating the reestablishment of a low redox level 
in the bottles.  The rapid reduction in headspace oxygen and visual observation of the 
change in media color indicated that the media in which the SRS enrichment culture is 
maintained is quite resilient to oxygen exposure. 
4.8 Effect of pH on Reductive Dechlorination of PCE and TCE 
 In order to evaluate the effect of pH on the SRS enrichment culture’s ability to 
reductively dechlorinate PCE and TCE, a treatment was included in which the pH was 
maintained at 7.0±0.25.  Results are presented in Figures 4.144-4.146.  Bottle #1 broke 
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on day 48, which is why no data are shown after that point.  In the other two bottles, the 
culture performed as expected, with rapid and repeatable reduction of PCE and TCE to 
ethene, with only low and transient levels of cDCE and VC observed.  Methane increased 
steadily.  pH levels were adjusted each time that headspace samples were taken.  Except 
for a brief excursion on days 48 and 55, the pH was maintained between 6.75 and 7.25 
(Figure 4.147).  At no time did the pH drop below 6.5. 
 The second treatment evaluated was also started at close to neutral pH, although 
no adjustments were made, and the pH was allowed to decrease as HCl produced from 
dechlorination accumulated.  As shown in Figures 4.148-4.150, these bottles behaved 
similarly to the treatment described above, since all were started under the same 
conditions.  There was only a transient increase in cDCE and VC during the first PCE 
and TCE dechlorination cycle.  Repeat additions of PCE and TCE were made at higher 
concentrations.  Gradually, with increasing amounts of dechlorination, the pH level 
started to decline (Figure 4.151), with the pH dropping below 6.0 near days 60, 70, and 
75 for bottles #1-#3.  The effect on the rate of ethene accumulation became apparent 
around day 63 for bottle #1 and day 70 for bottles #2 and #3.  The dechlorination of PCE 
and TCE began to slow, and accumulation of cDCE and VC increased with less 
accumulation of ethene. 
 Results for the triplicate bottles maintained at pH 6.5±0.25 are presented in 
Figures 4.152-4.154.  There was no apparent lag in PCE dechlorination, which was 
complete on day 14, however, a significant decrease in TCE did not occur until most of 
the PCE was consumed.  A large decrease in TCE occurred by day 14 and was complete 
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by day 20.  cDCE and VC accumulated transiently during the first cycle of PCE and TCE 
dechlorination, although ethene was the predominant terminal product.  Three more 
additions of PCE and TCE were made at increasing amounts.  PCE continued to be 
dechlorinated first, followed by TCE, with low and transient levels of cDCE and VC 
observed.  Ethene was consistently the predominant daughter product.  Methane also 
increased steadily.  As shown in Figure 4.155, the pH was successfully maintained within 
the target range. 
 Figures 4.156-4.158 present the results for the triplicate bottles that were 
maintained at pH 6.0±0.25.  There was no apparent lag in PCE dechlorination which was 
complete on day 14; however, a significant decrease in TCE did not occur until most of 
the PCE was consumed.  A significant decrease in TCE occurred by day 14 and was 
complete on day 20.  The predominant product from the first addition of PCE and TCE 
was cDCE in bottle #1, whereas a mixture of cDCE, VC, and ethene was observed for 
bottles #2 and #3.  A second PCE and TCE addition was made on day 20.  Bottle #1 
accumulated a large amount of cDCE, reaching a maximum on day 35.  VC accumulated 
in bottle #1 to a lesser degree, and reduction to ethene was nearly complete by day 63.  
Bottles #2 and #3 responded similarly to the second PCE and TCE addition.  A small 
amount of cDCE and VC accumulated simultaneously, with subsequent reduction to 
ethene.  Methane production occurred with no lag, but slowed considerably after day 28.  
As shown in Figure 4.159, the pH was successfully maintained within the target range. 
 Results for the triplicate bottles that were maintained at pH 5.5±0.25 are shown in 
Figures 4.160-4.162.  There was a lag of 6-13 days before any significant dechlorination 
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of PCE and TCE began and was then complete by day 20.  cDCE began to accumulate by 
day 14.  No VC or ethene production was detected.  After 48 days of incubation, 
reductive dechlorination stalled at cDCE.  A second addition of PCE and TCE was made 
on day 48.  This addition is not shown on Figure 4.160, as bottle #1 was broken and 
discarded prior to being respiked.  PCE and TCE were dechlorinated with no apparent lag 
accompanied by an increase in cDCE in bottle #2.  PCE and TCE were also dechlorinated 
in bottle #3, however, cDCE decreased and activity on all three chlorinated ethenes 
appeared to stall at day 70.  Methanogenesis began without lag and continued over the 
duration of the experiment, despite the low pH.  As shown in Figure 4.163, the pH was 
successfully maintained within the target range. 
 On the other side of the pH spectrum, one of the treatments for this experiment 
was maintained at a pH of 8.5±0.25.  Results for the triplicate bottles are shown in 
Figures 4.164-4.166.  Reductive dechlorination of PCE and TCE at this high pH was 
severely inhibited.  In bottles #1 and #2, there was only a modest decrease in PCE and 
TCE and a correspondingly minor accumulation of cDCE and VC.  In bottle #3, PCE was 
dechlorinated by day 48, although there was no evidence of TCE reduction and only 
minor amounts of cDCE and VC accumulation.  None of the pH 8.5 bottles produced 
ethene.  Methane production began with no lag and continued over the duration of the 
experiment.  As shown in Figure 4.167, the pH was successfully maintained within the 
target range, except for a slight dip below 8.25 on day 14. 
 A comparison of the microcosm treatments based on the first addition of PCE and 
TCE shows that a pH of 5.5 slowed the rate of PCE consumption by 4-5 days, while a pH 
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of 8.5 proved to be the most inhibitory (Figure 4.168).  pH levels of 6.5 and 6.0 did not 
significantly delay PCE consumption.  pH levels below 7.0 slowed the rate of TCE 
consumption, and a pH of 8.5 severely inhibited TCE consumption (Figure 4.169).  pH 
levels below 7.0 also increased the amount of cDCE that accumulated (Figures 4.170).  
VC accumulation was greatest at a pH of 6.0 (Figure 4.171).  Most importantly, complete 
reduction to ethene was significantly slowed at pH 6.5 and severely inhibited at pH 5.5, 
6.0 and 8.5 (Figure 4.172). 
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CHAPTER FIVE 
DISCUSSION 
 
 Given the promising results of Wood’s (45) previous work with the SRS 
enrichment culture, it was beneficial to further characterize the culture as it relates to 
other bioaugmentation cultures that chlororespire chlorinated ethenes.  The scope of this 
project included characterization of the SRS enrichment culture based on the range of 
TEAs used by the culture, potential pathogenicity, susceptibility to 1,1,1-TCA, use of 
EOS® as an alternative electron donor, and sensitivity to oxygen exposure and a range of 
pH levels.  Through this characterization, it was discovered that the SRS enrichment 
culture is capable of using a wide range of halogenated alkenes and alkanes including all 
of the chlorinated ethenes, 1,2-DCA, EDB, and VB.  The culture reductively 
dechlorinates HCB, PeCB, 1,2,4,5-TeCB, and 1,2,4-TCB in a manner that is suggestive 
of their use as TEAs.  The culture’s ability to dechlorinate the aromatic compounds in 
addition to the halogenated alkenes and alkanes, sets it apart from other mixed cultures 
that are able to dehalogenate alkenes and alkanes but not aromatics, and vice versa. 
 With respect to pathogenicity, the SRS enrichment culture does contain coliforms, 
but does not contain E. coli, which will aid in gaining regulatory approval for use of this 
culture in bioaugmentation.  Use of the SRS enrichment culture will be limited at sites 
co-contaminated with 1,1,1-TCA, which is inhibitory to complete reduction of PCE and 
TCE at 1,1,1-TCA concentrations of 3.7 µM and higher.  Although the SRS culture was 
enriched on lactate as the electron donor, a microcosm evaluation of EOS® as an alternate 
electron donor suggested that the culture performs better with EOS®.  This is 
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advantageous from the perspective that emulsified oils ferment more slowly and thereby 
provide donor over a longer period of time.  Lastly, the SRS enrichment culture proved to 
be quite resilient to oxygen exposure, but sensitive to pH levels below 6 and above 8.5.  
By completing this characterization, the properties of the SRS enrichment culture are 
better known with respect to other mixed cultures that are available for bioaugmentation.  
Further discussion of characteristics of the SRS culture is presented below. 
5.1 Types of Compounds Used as TEAs 
 The SRS enrichment culture is capable of utilizing the following halogenated 
alkenes and alkanes as TEAs:  PCE, TCE, cDCE, tDCE, 1,1-DCE, VC, EDB, 1,2-DCA, 
and VB.  The SRS culture contains several types of Dehalococcoides species; therefore, 
it is unclear which Dehalococcoides populations are responsible for the different 
dechlorination steps.  However, the findings of this study show that the SRS culture 
contains a Dehalococcoides consortium capable of chlororespiring all of the chlorinated 
ethenes, including the three dichloroethene isomers.  Table 5.1 compares the compounds 
used as TEAs by the SRS enrichment culture to other mixed cultures containing 
Dehalococcoides (VS, CBDB1, and KB-1TM), as well as several pure cultures of 
Dehalococcoides (strains 195, BAV1, GT, and FL2).  Like strain 195, BAV1, VS, and 
KB-1TM, the SRS enrichment culture can dechlorinate PCE to ethene.  However, the SRS 
enrichment culture utilizes all of the chlorinated ethenes as TEAs; a quality which none 
of the other cultures listed in Table 5.1 possesses (25, 35, 37).  The SRS enrichment 
culture is also unique from the perspective that its ability to use EDB and 1,2-DCA as 
TEAs has been confirmed.  The SRS culture’s ability to degrade these compounds has 
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potential application for bioaugmentation of sites contaminated with leaded gasoline.  
EDB and 1,2-DCA were once added to leaded gasoline, and evidence that these 
compounds continue to persist in the environment is mounting (18).  The SRS culture’s 
ability to use VB as a TEA is also of interest, as VB is a potential abiotic transformation 
product from dehydrohalogenation of EDB. 
 A quantitative comparison of the SRS enrichment culture to other cultures that 
use halogenated ethenes and ethanes as TEAs was achieved by calculating yield values in 
terms of gene copies per µmol of Cl- or Br- released.  Yields based on the Phase 2 TEA 
experiment are summarized in Table 5.2 and compared to previously reported values for 
other cultures.  Previous yield values for PCE, TCE, cDCE, VC, and 1,2-DCA were 
compiled by Duhamel and Edwards (11) based on a variety of Dehalococcoides cultures, 
including strain 195, KB-1TM, BAV1, and VS.  Most of the yields calculated for the SRS 
enrichment culture are on the same order of magnitude or slightly higher than the 
reported yields for other cultures.  The yield obtained for the SRS culture while using VB 
as the TEA was the highest reported, while the yield obtained for EDB was the lowest for 
this study.  Because the yield for EDB is so much lower than the other compounds, it is 
recommended that this result be verified through additional experimentation.  A lower 
yield on EDB versus 1,2-DCA is not expected based on thermodynamics, since 
dehalogenation of EDB is more energetically favorable than for 1,2-DCA (26). 
 The SRS enrichment culture is also capable of reductively dechlorinating several 
types of chlorinated aromatic compounds, including HCB, PeCB, 1,2,4,5-TeCB, and 
1,2,4-TCB.  Measurement of yields for these compounds was beyond the scope of this 
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research.  The pattern of reductive dechlorination suggests that these compounds are used 
as TEAs, i.e., a lag phase followed by increasing rates of consumption.  Nevertheless, in 
order to confirm their use as TEAs, additional experiments need to be run, including 
quantification of an increase in Dehalococcoides numbers using qPCR. 
 Reductive dechlorination of most of the chlorinated benzenes tested came as 
somewhat of a surprise.  The wetland area from which the SRS enrichment culture was 
developed actively dechlorinates chlorinated ethenes, and two previously described 
cultures that chlororespire chlorinated ethenes also show activity on at least one 
halogenated ethane (Table 5.1).  However, the wetland area at SRS does not appear to be 
contaminated with chlorinated benzenes, so activity on these compounds was not 
expected.  Most of the cultures that chlororespire chlorinated ethenes have not yet been 
tested for their ability to respire chlorinated benzenes.  The fact that the SRS culture 
contains a diverse population of Dehalococcoides with the ability to reductively 
dechlorinate chlorinated benzenes suggests these compounds may have been disposed of 
in the CBRP, and the ability to dechlorinate these compounds has been maintained. 
 Among the cultures listed in Table 5.1, the ability to use chlorinated benzenes as 
TEAs has only been reported for strain 195 and CBDB1 (2, 19, 28).  CBDB1 is capable 
of using HCB, PeCB, all TeCB isomers, 1,2,3-TCB, and 1,2,4-TCB as TEAs (2, 28).  
Fennell et al. (19) demonstrated the ability of strain 195 to use HCB, PeCB, 1,2,4,5-
TeCB, and 1,2,3,4-TeCB as TEAs.  Strain 195 can also cometabolically dechlorinate 
1,2,3,5-TeCB and the TCB isomers.  The SRS culture more closely resembles the 
dechlorination ability of CBDB1.  Although 1,2,3,5-TeCB was not directly tested, it was 
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apparent that the SRS culture can dechlorinate this isomer, as 1,3,5-TCB was detected in 
the PeCB treatment bottles as a dechlorination product, and 1,3,5-TCB can only be 
produced from dechlorination of 1,2,3,5-TeCB.  It is not clear if this activity is metabolic 
or cometabolic, but this result warrants further testing of the other TeCB and TCB 
isomers as sole electron acceptors. 
 The most frequently reported pathway for reductive dechlorination of HCB is (27, 
49): 
HCB → PeCB → 1,2,3,5-TeCB → 1,3,5-TCB 
This also happens to be the most energetically profitable pathway (5).  The proposed 
pathway for reductive dechlorination of chlorinated benzenes by the SRS culture is 
shown in Figure 5.1.  Pathways for chlorobenzene reductive dechlorination used by other 
cultures are also shown (2, 5, 19, 28, 49).  To further investigate the SRS culture’s use of 
the chlorinated benzenes as TEAs and better quantify the results, an improved method of 
chlorobenzene analysis should be implemented, such as a liquid extraction analysis using 
internal standards. 
5.2 Pathogenicity of the SRS Culture 
 The source of inoculum for the SRS enrichment culture was soil from the Twin 
Lakes wetland at SRS.  This, in addition to the manner in which the culture was enriched, 
suggested that it was unlikely that the culture contains pathogenic microorganisms.  The 
presence of coliforms was confirmed.  Since various types of coliforms are commonly 
found in soil, this was not a surprising outcome.  More importantly, E. coli is not present 
in the SRS enrichment culture. 
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 Investigation of pathogenicity of the enrichment culture was included in the scope 
of this thesis, due to health and safety concerns that accompany injection of a microbial 
culture into a groundwater supply.  Pathogenicity data on bioaugmentation cultures is 
limited.  Use of some cultures has been restricted while others have been permitted.  For 
example, B. cepacia has a broad range of biodegradation capabilities, although it has also 
been identified as an opportunistic human pathogen implicated in severe infections in 
immuno-compromised populations (3).  B. cepacia has a high potential for adaptability 
and genetic exchange as well as a multidrug resistant phenotype (22, 44).  Due to this 
information, the U.S. Environmental Protection Agency has applied strict regulations on 
the use of B. cepacia. 
A number of pure and mixed cultures have been permitted for use in 
bioaugmentation.  Methylosinus trichosporium OB3b, KB-1TM, and mixed cultures from 
Bioremediation Consulting, Inc. have been reported as nonpathogenic (16, 34).  
However, the testing methods and frequency of testing were not reported and may vary.  
The MSDS that accompanies the KB-1TM culture reports that the culture tested negative 
for a variety of pathogenic organisms including:  Salmonella sp., Listeria monocytogenes, 
Vibrio sp., Camplyobacter sp., Clostridia sp., Bacillus anthracis, Pseudomonas 
aeruginosa, Yersinia sp., yeast and mold, fecal coliforms, and Enterococci.  In contrast, 
the MSDS for the SDC-9 bioaugmentation culture from the Shaw Group, Inc. does not 
include information on pathogenicity testing.  Molecular testing of the SRS culture for 
specific pathogenic microorganisms other than E. coli is being conducted by Dr. 
Christopher Bagwell at SRNL to further evaluate pathogenicity of the SRS culture. 
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5.3 Inhibition of Chloroethene Respiration by 1,1,1-TCA 
 Other bioaugmentation cultures have been shown to be inhibited by the presence 
of low concentrations of 1,1,1-TCA and chloroform (13, 23).  Grostern and Edwards (23) 
documented inhibitory effects on the KB-1TM culture amended with 1,1,1-TCA at a 
concentration of 300 µM, an equimolar concentration of TCE, and a 25% inoculum (v/v).  
TCE degradation was halted at cDCE and VC with no ethene production, and no 1,1,1-
TCA conversion was observed.  The same inhibition pattern was also documented at a 
concentration of 30 µM for both 1,1,1-TCA and TCE and a 10% inoculum.  In this study, 
the SRS culture was also inhibited by 300 µM 1,1,1-TCA.  Reductive dechlorination of 
TCE to ethene was slowed and conversion of VC to ethene was inhibited; there was 
complete inhibition of methanogenesis.  Unlike KB-1TM, the SRS culture produced some 
ethene.  A major difference between the Grostern and Edwards (23) study and this study 
was the percent inocula.  In this study, an undiluted inoculum was used to test the high 
1,1,1-TCA concentration.  The percent inoculum may have an effect on the extent of 
inhibition, as KB-1TM accumulated more cDCE and the SRS culture accumulated more 
VC and ethene as terminal products. 
 Duhamel et al. (13) also reported slowed rates of VC to ethene conversion with 
KB-1TM at a much lower 1,1,1-TCA concentration of 5.2 µM and a 10% inoculum.  
During Phase 2 of the inhibition experiment, the SRS enrichment culture was uninhibited 
at 5 µM 1,1,1-TCA, suggesting that the SRS culture has a higher tolerance to 1,1,1-TCA 
than KB-1TM.  In response to the problem presented by 1,1,1-TCA, SiREM (the company 
that markets KB-1TM) offers a culture (referred to as MS) that contains Dehalobacter spp. 
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that reductively dechlorinate 1,1,1-TCA.  Co-inoculation of KB-1TM and MS allows 
cDCE and VC degradation to ethene to proceed after MS has dechlorinated all of the 
1,1,1-TCA to 1,1-DCA, which is not inhibitory (23).  A similar approach may be 
necessary if the SRS culture is used in the presence of 1,1,1-TCA.  Other vendors have 
reported mixed cultures capable of dechlorinating TCE that are resistant to inhibition by 
1,1,1-TCA (1, 6).  Adamson and Parkin (1) reported transformation of 1,1,1-TCA to 1,1-
DCA and partially to CA by a lactate- and PCE-enriched culture.  It is conceivable that 
the SRS culture could be grown with a 1,1,1-TCA dechlorinator so that a single source 
could be used in bioaugmentation. 
5.4 Use of Emulsified Vegetable Oil as an Electron Donor 
 Wood (45) tested the effectiveness of emulsified vegetable oil as an electron 
donor for biostimulation of microcosms prepared with soil and groundwater from the P-
Area at SRS.  As with the other biostimulation treatments, emulsified vegetable oil was 
not effective.  This was in contrast to a number of studies that have demonstrated the 
effectiveness of vegetable oil for biostimulation (30, 31, 50).  However, Wood did not 
test the feasibility of vegetable oil as a substrate for bioaugmentation with the SRS 
culture.  For this research, the use of emulsified vegetable oil was compared to lactate as 
an electron donor for the SRS enrichment culture.  Results of the experiment with EOS® 
suggested that EOS® is a better electron donor than lactate, as the reductive 
dechlorination of PCE and TCE occurred faster in treatments amended with EOS® and 
with less accumulation of daughter products. 
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 The initial concentration of TCE in some of the EOS®-amended bottles was lower 
than that in the lactate-amended bottles.  The large drop in TCE concentration was most 
likely a result of partitioning of the TCE into the oil phase, as well as a lack of 
equilibrium, as the lactate-amended bottles also experienced an initial drop in TCE 
concentration.  The tailing effect observed with TCE in the EOS®-amended bottles also 
suggests that some of the TCE partitioned into the oil phase.  This apparently led to slow 
diffusion of cDCE and VC into the liquid phase, producing a steady level of VC during 
the last portion of incubation.  Although partitioning of the chlorinated ethenes into the 
oil may extend the time needed for complete dechlorination to ethene, emulsified oil has 
the added benefit of slower fermentation and longer retention in a contaminated aquifer.  
These characteristics of emulsified oil may lower operating and maintenance costs 
typically associated with repeat injections of soluble carbon sources such as lactate (17). 
5.5 Tolerance of the SRS Culture to Oxygen 
 Additional characterization of the SRS culture included its tolerance to oxygen 
exposure.  Dehalococcoides are strictly anaerobic microorganisms, and the success of 
bioaugmentation cultures in the field depends in part on preventing oxygen exposure.  
The sensitivity of bioaugmentation cultures to oxygen likely varies, as not all cultures are 
maintained under the same conditions.  In one study, Seepersad (39) demonstrated a 
decrease in TCE degradation rate in microcosms containing approximately 0.3 mg/L 
oxygen in the headspace of the bottles.  The SRS enrichment culture is capable of 
sustaining at least 24 hours of exposure to air (21% oxygen) without any permanent 
effect on reductive dechlorination of PCE and TCE to ethene.  Like the culture in 
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Seepersad’s experiment, the SRS culture experienced slowed dechlorination rates of 
PCE, TCE, cDCE, and VC, but complete dechlorination to ethene did eventually occur 
following a return to anaerobic conditions.  The SRS enrichment culture’s resilience to 
oxygen exposure is a positive characteristic which will make field deployment of the 
culture easier. 
 It is unlikely that the SRS culture will be exposed to aerobic conditions for as 
long as 24 hours.  However, if oxygen exposure did occur, the SRS culture would most 
likely be able to retain its dechlorinating activity after anaerobic conditions are 
established.  Given the results of the oxygen tolerance experiment, the success of the SRS 
enrichment culture will not be greatly affected by potential oxygen exposure during 
injection of the culture into groundwater. 
 It should be noted that the oxygen tolerance experiment was performed in the 
anaerobic media used to maintain the SRS culture.  This media has a substantial quantity 
of iron sulfides present to serve as a redox buffer.  Although there were indications that 
the media in contact with the air became oxidized during the quiescent incubation period 
(i.e., the liquid turned pink and the black iron sulfides turned grey), it is possible that the 
same experiment conducted with groundwater and a low inoculum of the SRS culture 
might yield a less favorable result.  The experiment does indicate, however, that brief 
exposure of the culture to air during addition to groundwater should not present a 
problem, as long as a low redox level exists in the groundwater. 
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5.6 Effect of pH on Reductive Dechlorination of PCE and TCE 
 In addition to the importance of the culture’s sensitivity to oxygen exposure, its 
sensitivity to various pH conditions is also relevant.  The SRS enrichment culture has 
been maintained at a pH of 6.5-7.5 in a buffered mineral medium, as that is the accepted 
optimum pH range for chlororespiring bacteria (32).  However, the cost to buffer the pH 
of groundwater to neutral may become a large portion of the total cost of 
bioaugmentation.  If the culture can sustain activity at lower pH levels, the operating and 
maintenance costs associated with adjusting the groundwater pH could be significantly 
lowered.  When exposed to a pH of 6.0, the dechlorinating activity of the SRS enrichment 
culture was slowed and increased accumulation of cDCE and VC occurred.  At pH 5.5, 
reductive dechlorination stopped at cDCE and no VC or ethene was produced.  This 
strong inhibition is evidence that the SRS enrichment culture cannot tolerate pH levels 
less than 6.0, and groundwater will have to be adjusted to pH 6.5 or higher prior to 
bioaugmentation.  Also, the SRS culture was unable to dechlorinate PCE and TCE at a 
pH of 8.5. 
 KB-1TM has been reported to be completely inhibited below pH 5.0 and above pH 
10; the optimal range given for the KB-1TM culture is between 6.0 and 8.3 (38).  Zhuang 
and Pavlostathis (51) conducted a pH assay similar to the one in this study and found that 
neutral pH was optimum for reductive dechlorination by a methanogenic mixed culture 
capable of dechlorinating PCE to VC.  The mixed culture was exposed to pH levels of 4, 
6, 7, 8, and 9.5.  PCE to TCE dechlorination was similar in the pH 7 and 8 treatments, but 
the end products were VC and cDCE, respectively.  Significant accumulation of cDCE 
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was also observed at pH 6 with less PCE dechlorination than the pH 7 and 8 treatments.  
At pH 4 and 9.5, there was limited dechlorination of PCE, along with accumulation of 
cDCE and no VC. 
 The SRS culture’s response to a gradual decrease in pH was evaluated by not 
adjusting pH over the course of several PCE and TCE additions.  The pH was allowed to 
decrease below 7.0 due only to acid generation from reductive dechlorination of the PCE 
and TCE.  The expectation was that at pH levels below 6.5, reductive dechlorination 
would be inhibited.  After the pH dropped below 6.0, these bottles began to show signs of 
decreased activity; e.g., VC began to accumulate.  This is similar to the findings of Fogel 
et al. (20).  Desulfitobacterium dichloroeliminans strain DCA1, a non-Dehalococcoides 
dehalorespirator, has an optimal pH range of 7.2-7.8 but maintained activity at pH levels 
as low as 5.4, caused by release of HCl (33).  Although many investigators report the 
need to maintain dechlorinating cultures at a neutral pH, these claims are not 
substantiated extensively in the literature. 
 With that in mind, it is important to note that the SRS enrichment culture was 
developed from C-Area sediment where natural attenuation of PCE and TCE to ethene is 
occurring.  The same C-Area sediment and groundwater were used to set up microcosms 
for an experiment not included in this thesis.  The initial pH of the C-Area groundwater 
was 5.5 and was not adjusted to neutral at any time during the experiment.  Despite this 
low pH, the microcosms successfully dechlorinated VC to ethene and ethane over several 
additions of VC.  This indicated that the Dehalococcoides present at the C-Area site are 
capable of tolerating pH levels below 6.0 and that it may be possible to develop a 
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bioaugmentation culture that is able to grow at a low pH.  This is of considerable interest, 
as it would eliminate the need to adjust groundwater pH for bioaugmentation. 
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CHAPTER SIX 
CONCLUSIONS 
 
 Based on the research performed for this thesis, the following conclusions were 
reached: 
1. The SRS enrichment culture is capable of utilizing the following halogenated 
ethenes and ethanes as TEAs:  PCE, TCE, cDCE, tDCE, 1,1-DCE, VC, EDB, 1,2-DCA, 
and VB.  The SRS culture can reductively dehalogenate all of these compounds at 
concentrations similar to the highest concentrations of PCE and TCE (15 and 38 mg/L, 
respectively) found in groundwater in the P-Area at SRS.  Growth yields calculated for 
the SRS enrichment culture, with the exception of EDB, are within the same order of 
magnitude reported for other Dehalococcoides-containing cultures, ranging from 7.9x107 
cells/µmol Cl- for VC to 1.8x109 cells/µmol Cl- for 1,2-DCA.  The culture also 
reductively dechlorinates the chlorinated aromatic compounds HCB, PeCB, 1,2,4,5-
TeCB, and 1,2,4-TCB.  Although the pattern and rate of dechlorination is suggestive of 
growth, use of these aromatics as TEAs has not yet been established due to a lack of 
qPCR data correlating an increase in the population of Dehalococcoides to chloride 
release. 
2. The SRS enrichment culture tested positive for coliforms using two types of 
commercial media (Colilert® and ReadyCult®).  More importantly, however, it tested 
negative for the presence of E. coli.  This confirms the absence of at least one important 
type of potential pathogen in the culture.  Further evaluation is warranted to demonstrate 
that other potential pathogens are absent from the culture.  Demonstrating the absence of 
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pathogenic microbes in the SRS culture will facilitate receiving approval for use of the 
culture at SRS, by assuring regulators that no health threat is posed to the groundwater by 
introduction of the culture. 
3. The SRS enrichment culture is inhibited by the presence of 1,1,1-TCA at 
concentrations of 3.6 µM (0.48 mg/L) and higher.  The inhibition is most significant for 
the critical step of VC reduction to ethene.  At a concentration of 300 µM 1,1,1-TCA (40 
mg/L), the SRS culture was strongly inhibited in its ability to dechlorinate VC to ethene 
after 42 days of incubation.  This susceptibility to 1,1,1-TCA will limit the SRS culture’s 
use at sites co-contaminated with chlorinated ethenes and 1,1,1-TCA.  Such a limitation 
may be overcome by first bioaugmenting with a culture that is capable of dechlorinating 
1,1,1-TCA, thereby eliminating its inhibitory effect. 
4. The SRS enrichment culture utilizes EOS®, a commercial form of emulsified 
vegetable oil, as an electron donor for reductive dechlorination of PCE and TCE.  
Reductive dechlorination occurs at faster rates than when lactate is used as the electron 
donor.  Although the SRS culture was enriched and maintained with lactate serving as the 
electron donor, microcosms amended with EOS® accumulated less daughter products and 
produced ethene at a faster rate.  Bioaugmentation with EOS® may be beneficial as 
emulsified oil is a much longer lasting donor than lactate and may reduce the costs 
associated with repeat feedings of lactate.  Among the four varieties of EOS® tested (450, 
598, 598B42, 598B42 + Vitamin B12), the rate of  ethene production was initially faster 
in microcosms amended with EOS® 450 and EOS® 598, although the final level of ethene 
was reached at approximately the same time for all varieties. 
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5. The SRS enrichment culture is resilient to at least 24 hours of quiescent exposure 
to air (21% oxygen).  The culture’s ability to dechlorinate PCE and TCE is slowed after 
oxygen exposure, taking approximately 4 times longer to completely dechlorinate PCE 
and TCE.  In spite of this effect on the rate, the culture does retain its ability to 
completely reduce PCE and TCE to ethene.  The presence of iron sulfides in the mineral 
media likely played a role in reducing oxidative damage to the culture during oxygen 
exposure.  The resilience of the culture implies it will survive a brief period of exposure 
to oxygen during field application, assuming low redox conditions have been pre-
established in the groundwater. 
6. The SRS enrichment culture is inhibited by pH levels below 6.0 and above 8.5.  
At pH 6.0, reductive dechlorination of PCE and TCE slowed and cDCE and VC 
accumulated.  At pH 5.5, dechlorination stalled at cDCE, with no production of VC or 
ethene.  Reductive dechlorination of PCE and TCE was severely inhibited at a pH level 
of 8.5.  When the pH of the culture was allowed to gradually decrease from neutral as 
repeated additions of PCE and TCE were dechlorinated (by release of HCl and no 
addition of a base), ethene formation slowed considerably once the pH dropped below 
6.0.  Given the inhibitory effect of pH levels below 6.0, the pH of the P-Area 
groundwater should be adjusted within the range of 6.5-7.5 for successful 
bioaugmentation to occur.  Sufficient buffer must also be available to prevent the pH 
from decreasing below 6.0 as HCl is released during PCE and TCE dechlorination. 
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Table 3.1  Initial and maximum amounts of TEAs added and Henry’s constants for the TEAs, ethene, ethane, and methane. 
 
   Initial Maximum 
 
 
  Concentration Volume Added Concentration Volume Added Hc   
TEA µmol/bottle (mg/L) (mL sat. H2O) µmol/bottle (mg/L) (µL neat) dimensionless Referencea 
PCE 3.0 3.6 2.6 12.0 17.0 1.5 0.64 A 
TCE 7.5 8.2 0.9 36.0 39.0 3.5 0.35 A 
cDCE 9.5 8.5 0.2 36.0 32.0 2.7 0.14 A 
tDCE 6.5 2.4 0.1 36.0 29.0 2.7 0.35 A 
1,1-DCE 7.0 4.3 0.3 36.0 22.0 2.9 0.97 A 
VC 7.0 2.8  – b 48.0 19.0  – b 1.01 A 
1,2-DCA 5.0 4.7 0.06 23.0 20.0 2.0 0.05 B 
EDB 2.7 5.0 0.125 24.0 23.0 2.0 0.03 B 
VB 7.0 5.8  – b 48.0 39.0  – b 0.50 B 
HCB 0.0011 0.0031   70c 0.0011 0.0031   70c 0.024 B 
PeCB 0.4 1.0  75c 0.4 1.0  75c 0.029 B 
1,2,4,5-
TeCB 0.2 0.4   150c 0.2 0.4   150c 0.041 B 
1,2,4-TCB 8.0 13.9   1.0d 16.0 27.7 2.0 0.058 B 
1,2-DCB 9.0 12.7   1.0d 17.8 25.0 2.0 0.077 B 
1,3-DCB 9.0 12.3   1.0d 17.5 23.9 2.0 0.11 B 
1,4-DCB 0.10 0.13   100c 0.19 0.26  200c 0.10 B 
CB 9.9 10.2   1.0d 29.6 30.5 3.0 0.15 B 
Ethene N/Ae N/A N/A N/A N/A N/A 7.24 B 
Ethane N/A N/A N/A N/A N/A N/A 17 B 
Methane N/A N/A N/A N/A N/A N/A 1188 C 
a A = ref (21), B = ref (43), and C = ref (41);b Added as neat gas; 0.175 mL initially; 1.5 mL maximum; c Added dissolved in acetone 
(µL); d Added as neat compound (µL); e N/A = Compound was not added as a TEA 
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Table 4.1  TEA Experiment (Phase 1) percent recoveries of TEAs as ethene and 
percentage of lactate added that was used for dechlorination of the respective TEA and 
methanogenesis (based on electron equivalents). 
 
Treatment 
  
% Recovered 
as Ethene 
% lactate added used 
for dechlorination 
% lactate added used 
for methanogenesis 
PCE 89% 0.32% 6.6% 
TCE 104% 0.32% 3.2% 
cDCE 111% 0.42% 0.50% 
tDCE 47% 0.12% 12% 
1,1-DCE 110% 0.42% 6.4% 
VC 109% 0.56% 4.6% 
1,2-DCA 94% 0.44% 2.0% 
EDB 112% 0.56% 0.53% 
 
 
Table 4.2  TEA Experiment (Phase 2) percent recoveries of TEAs as ethene and 
percentage of lactate added that was used for dechlorination of the respective TEA and 
methanogenesis (based on electron equivalents). 
 
Treatment 
  
% Recovered 
as Ethene 
% lactate added used 
for dechlorination 
% lactate added used 
for methanogenesis 
PCE 83% 0.74% 1.5% 
TCE 91% 0.79% 0.83% 
cDCE 80% 0.58% 0.39% 
tDCE 93% 0.66% 1.1% 
1,1-DCE 72% 0.60% 1.6% 
VC 91% 0.79% 1.7% 
1,2-DCA 94% 0.41% 1.3% 
EDB 84% 0.60% 0.086% 
VB 95% 0.81% 0.66% 
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Table 4.3  qPCR data and calculated yield values for TEA Experiment Phase 2. 
  
Cl- or Br- 
releaseda 
(µmol/bottle) 
Final gene 
copies 
(DHC/mL) 
Initial gene 
copies 
(DHC/mL) 
Net gene copies 
(DHC/mL) 
Yield (gene 
copies/µmol Cl- 
or Br-) 
Compound Ave Stdev Ave Stdev Ave Stdev Ave Stdev Ave Stdev 
PCE 210 4.81 3.5x109 2.8x108 1.1x106 2.0x105 3.5x109 2.83x108 1.7x109 1.4x108 
TCE 306 5.23 5.2x108 3.4x108 1.1x106 2.0x105 5.2x108 3.37x108 1.7x108 1.1x108 
cDCE 222 18.1 2.8x109 7.7x107 1.1x106 2.0x105 2.8x109 7.67x107 1.3x109 1.1x108 
tDCE 216 9.27 8.3x108 6.7x107 1.1x106 2.0x105 8.3x108 6.67x107 3.8x108 3.5x107 
1,1-DCE 207 28.7 1.2x109 8.7x107 1.1x103 7.6x101 1.2x109 8.67x107 5.9x108 9.3x107 
VC 210 35.1 1.7x108 1.6x107 2.2x105 1.4x104 1.7x108 1.60x107 7.9x107 1.5x107 
1,2-DCA 218 2.75 4.0x109 1.1x108 1.2x106 2.2x104 4.0x109 1.10x108 1.8x109 5.6x107 
EDB 275 10.3 1.9x106 7.7x104 1.8x102 6.0x100 1.9x106 7.67x104 6.8x105 3.8x104 
VB 232 0.142 4.3x109 2.7x108 4.5x102 6.0x101 4.2x109 2.67x108 1.8x109 1.2x108 
 a
 Calculated based on the amount of parent compound consumed and daughter products formed; chloride and bromide 
 were not directly measured. 
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Table 4.4  Ratios of electron equivalents used for dechlorination and methanogenesis to electron equivalents of lactate added. 
 
% Daughter Product Formed 
Treatment PeCB 
1,2,4,5- 
TeCB 
1,3,5-
TCB 
1,2,4-
TCB 
1,4-
DCB 
1,3-
DCB 
1,2-
DCB CB Benzene Total 
% lactate used 
for 
dechlorinationa 
% lactate used 
for 
methanogenesis 
HCB 3% 58% 0% 32% 0% 0% 0% 0% 0% 93% 0.00021% 12.1% 
PeCB 
-- 2% 33% 7% 32% 0% 11% 0% 0% 85% 0.076% 8.7% 
1,2,4,5-
TeCB -- -- 0% 27% 38% 0% 18% 0% 0% 83% 0.038% 9.6% 
1,2,4-TCB 
-- -- -- -- 40% 0% 16% 2% 0% 58% 0.76% 24% 
1,4-DCB 
-- -- -- -- -- -- -- 0% 0% 0% N/Ab 74% 
1,3-DCB 
-- -- -- -- -- -- -- 0% 0% 0% N/A 69% 
1,2-DCB 
-- -- -- -- -- -- -- 0% 0% 0% N/A 61% 
CB 
-- -- -- -- -- -- -- -- 0% 0% N/A 69% 
 a
 Ratio calculated based on electron equivalents required to produce major end product. 
 b
 N/A = no significant dechlorination 
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Table 4.5  Comparison of average percent loss of chlorinated benzenes in water controls 
and live bottles. 
 
Average % Loss Treatment WCs Live Bottles 
HCB 0% 100% 
PeCB 0% 100% 
1,2,4,5-TeCB 0% 100% 
1,2,4-TCB 69% 100% 
1,4-DCB 29% 0% 
1,3-DCB 53% 51% 
1,2-DCB 49% 52% 
CB 45% 33% 
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Table 5.1  Comparison of SRS enrichment culture and other bioaugmentation cultures.a 
Compound 
strain 195 
(Cornell) 
BAV1 
(Pinellas) 
GT 
(Pinellas) 
VS 
(Victoria) 
FL2 
(Pinellas) 
CBDB1 
(Pinellas) 
KB-1 
(Pinellas) 
SRS 
Enrichment 
Culture 
PCE + (35) ● (25) - (40) ● (37) ● (24) - (8) + + 
TCE + (35) ● (25) + (40) + (37) + (24) ? + (12) + 
cDCE + (35) + (25) + (40) + (37) + (24) ? + (12) + 
tDCE ● (35) + (25) - (40) + (37) + (24) ? ? + 
1,1-DCE + (35) + (25) + (40) + (37) - (24) ? + (13) + 
VC ● (35) + (25) + (40) + (37) ● (24) ? + (12) + 
1,2-DCA + (35) + (25) - (40) ? - (24) ? ?  + 
EDB + (36) ? ? ? ? ? ? + 
VB ? + (25) - (40) ? ? ? ? + 
CB - (19) ? ? ? ? - (2) ? - 
1,2-DCB - (19) ? ? ? ? ? ? - 
1,3-DCB - (19) ? ? ? ? ? ? - 
1,4-DCB - (19) ? ? ? ? ? ? - 
1,2,3-TCB ● (19) ? ? ? ? + (2) ? ? 
1,2,4-TCB ● (19) ? ? ? ? + (2) ?  
1,3,5-TCB ● (19) ? ? ? ? - (2) ? ? 
1,2,3,4-TeCB + (19) ? ? ? ? + (2) ? ? 
1,2,3,5-TeCB ● (19) ? ? ? ? + (2) ? ? 
1,2,4,5-TeCB + (19) ? ? ? ? + (2) ?  
PeCB + (19) ? ? ? ? + (28) ?  
HCB + (19) ? ? ? ? + (28) ?  
a
 + = used as a TEA, - = not used as a TEA, ● = used cometabolically,  = reductively dechlorinated, not evaluated 
for chlororespiration, ? = not tested as a TEA 
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Table 5.2.  Summary of reported yields for Dehalococcoides cultures. 
TEA Averagea 
Standard 
Deviationa 
Terminal 
Product Referenceb 
PCE 6.9x108 --- ethene Dc 
  1.7x109 1.4x108 ethene A 
TCE 3.6x108 1.3x108 ethene C 
  7.1x108 3.6x108 cDCE Bc 
  1.7x108 1.1x108 ethene A 
cDCE 2.7x108 5.6x107 ethene B 
  1.3x109 1.1x108 ethene A 
tDCE 3.8x108 3.5x107 ethene A 
1,1-DCE 5.9x108 9.3x107 ethene A 
VC 1.2x108 1.4x107 ethene Fc 
  6.3x107 1.0x107 ethene F 
  5.2x108 1.5x108 ethene E 
  5.6x108 1.4x108 ethene C 
  2.7x108 5.6x107 ethene Bc 
  7.9x107 1.5x107 ethene A 
1,2-DCA 3.7x106 3.9x105 ethene Gc 
  1.4x108 2.8x107 ethene Bc 
  1.8x109 5.6x107 ethene A 
EDB 6.8x105 3.8x104 ethene A 
VB 1.8x109 1.2x108 ethene A 
 a
 Yields and standard deviations are in reported in units of copies/µmol Cl-
 released. 
 b
 A = This study, B = ref (11), C = ref (12), D = ref (4), E = ref (10), F = ref (25),
 G = ref (35) 
 c
 Original units of reported yields were converted using assumptions used by 
 Duhamel and Edwards (11). 
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Figure 3.1  Diagram of inocula sources for Phase 1 and Phase 2 of the Alternate TEA Experiment. 
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Figure 4.1  First cycle of PCE and TCE dechlorination in Canister #1. 
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Figure 4.2  First cycle of PCE and TCE dechlorination in Canister #2. 
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Figure 4.3  Cumulative PCE and TCE dechlorinated and ethene produced in Canister #1. 
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Figure 4.4  Cumulative PCE and TCE dechlorinated and ethene produced in Canister #2. 
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Figure 4.5  Results for one of the Yield Experiment Phase 1 PCE bottles (PCE-1). 
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Figure 4.6  Results for one of the Yield Experiment Phase 1 PCE bottles (PCE-2). 
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Figure 4.7  Results for one of the Yield Experiment Phase 1 PCE bottles (PCE-3). 
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Figure 4.8  Results for one of the Yield Experiment Phase 1 TCE bottles (TCE-1). 
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Figure 4.9  Results for one of the Yield Experiment Phase 1 TCE bottles (TCE-2). 
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Figure 4.10  Results for one of the Yield Experiment Phase 1 TCE bottles (TCE-3). 
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Figure 4.11  Results for one of the Yield Experiment Phase 1 cDCE bottles (cDCE-1). 
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Figure 4.12  Results for one of the Yield Experiment Phase 1 cDCE bottles (cDCE-2). 
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Figure 4.13  Results for one of the Yield Experiment Phase 1 cDCE bottles (cDCE-3). 
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Figure 4.14  Results for one of the Yield Experiment Phase 1 tDCE bottles (tDCE-1). 
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Figure 4.15  Results for one of the Yield Experiment Phase 1 tDCE bottles (tDCE-2). 
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Figure 4.16  Results for one of the Yield Experiment Phase 1 tDCE bottles (tDCE-3). 
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Figure 4.17  Results for one of the Yield Experiment Phase 1 1,1-DCE bottles (1,1-DCE-1). 
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Figure 4.18  Results for one of the Yield Experiment Phase 1 1,1-DCE bottles (1,1-DCE-2). 
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Figure 4.19  Results for one of the Yield Experiment Phase 1 1,1-DCE bottles (1,1-DCE-3). 
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Figure 4.20  Results for one of the Yield Experiment Phase 1 VC bottles (VC-1). 
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Figure 4.21  Results for one of the Yield Experiment Phase 1 VC bottles (VC-2). 
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Figure 4.22  Results for one of the Yield Experiment Phase 1 VC bottles (VC-3). 
  
123 
0
5
10
15
20
25
30
0 50 100 150 200 250
Time (days)
1
,
2
-
D
C
A
 
(
µ
µ µ
µ
m
o
l
/
b
o
t
t
l
e
)
0
20
40
60
80
100
120
140
160
E
t
h
e
n
e
 
a
n
d
 
M
e
t
h
a
n
e
 
(
µ
µ µ
µ
m
o
l
/
b
o
t
t
l
e
)
1,2-DCA Ethene Methane lactate addition
 
 
 
Figure 4.23  Results for one of the Yield Experiment Phase 1 1,2-DCA bottles (1,2-DCA-1). 
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Figure 4.24  Results for one of the Yield Experiment Phase 1 1,2-DCA bottles (1,2-DCA-2). 
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Figure 4.25  Results for one of the Yield Experiment Phase 1 1,2-DCA bottles (1,2-DCA-3). 
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Figure 4.26  Results for one of the Yield Experiment Phase 1 EDB bottles (EDB-1). 
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Figure 4.27  Results for one of the Yield Experiment Phase 1 EDB bottles (EDB-2). 
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Figure 4.28  Results for one of the Yield Experiment Phase 1 EDB bottles (EDB-3). 
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Figure 4.29  Results for the first set of Yield Experiment Phase I WCs (average of triplicates).  Error bars represent ± one 
standard deviation. 
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Figure 4.30  Results for the second set of Yield Experiment Phase I WCs (average of triplicates).  Error bars represent ± 
one standard deviation. 
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Figure 4.31  Results for one of the Yield Experiment Phase 2 PCE bottles (PCE-1). 
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Figure 4.32  Results for one of the Yield Experiment Phase 2 PCE bottles (PCE-2). 
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Figure 4.33  Results for one of the Yield Experiment Phase 2 PCE bottles (PCE-3). 
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Figure 4.34  Results for one of the Yield Experiment Phase 2 TCE bottles (TCE-1). 
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Figure 4.35  Results for one of the Yield Experiment Phase 2 TCE bottles (TCE-2). 
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Figure 4.36  Results for one of the Yield Experiment Phase 2 TCE bottles (TCE-3). 
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Figure 4.37  Results for one of the Yield Experiment Phase 2 cDCE bottles (cDCE-1). 
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Figure 4.38  Results for one of the Yield Experiment Phase 2 cDCE bottles (cDCE-2). 
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Figure 4.39  Results for one of the Yield Experiment Phase 2 cDCE bottles (cDCE-3). 
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Figure 4.40  Results for one of the Yield Experiment Phase 2 tDCE bottles (tDCE-1). 
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Figure 4.41  Results for one of the Yield Experiment Phase 2 tDCE bottles (tDCE-2). 
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Figure 4.42  Results for one of the Yield Experiment Phase 2 tDCE bottles (tDCE-3). 
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Figure 4.43  Results for one of the Yield Experiment Phase 2 1,1-DCE bottles (1,1-DCE-1). 
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Figure 4.44  Results for one of the Yield Experiment Phase 2 1,1-DCE bottles (1,1-DCE-2). 
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Figure 4.45  Results for one of the Yield Experiment Phase 2 1,1-DCE bottles (1,1-DCE-3). 
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Figure 4.46  Results for one of the Yield Experiment Phase 2 VC bottles (VC-1). 
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Figure 4.47  Results for one of the Yield Experiment Phase 2 VC bottles (VC-2). 
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Figure 4.48  Results for one of the Yield Experiment Phase 2 VC bottles (VC-3). 
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Figure 4.49  Results for one of the Yield Experiment Phase 2 1,2-DCA bottles (1,2-DCA-1). 
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Figure 4.50  Results for one of the Yield Experiment Phase 2 1,2-DCA bottles (1,2-DCA-2). 
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Figure 4.51  Results for one of the Yield Experiment Phase 2 1,2-DCA bottles (1,2-DCA-3). 
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Figure 4.52  Results for one of the Yield Experiment Phase 2 EDB bottles (EDB-1). 
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Figure 4.53  Results for one of the Yield Experiment Phase 2 EDB bottles (EDB-2). 
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Figure 4.54  Results for one of the Yield Experiment Phase 2 EDB bottles (EDB-3). 
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Figure 4.55  Results for one of the Yield Experiment Phase 2 VB bottles (VB-1). 
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Figure 4.56  Results for one of the Yield Experiment Phase 2 VB bottles (VB-2). 
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Figure 4.57  Results for one of the Yield Experiment Phase 2 VB bottles (VB-3). 
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Figure 4.58a  Results for one of the TEA Experiment HCB bottles (HCB-1); data for HCB and methane. 
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Figure 4.58b  Results for one of the TEA Experiment HCB bottles (HCB-1); data for PeCB, 1,2,4,5-TeCB, and 1,2,4-TCB. 
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Figure 4.59a  Results for one of the TEA Experiment HCB bottles (HCB-2); data for HCB and methane. 
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Figure 4.59b  Results for one of the TEA Experiment HCB bottles (HCB-2); data for PeCB, 1,2,4,5-TeCB, and 1,2,4-TCB. 
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Figure 4.60a  Results for one of the TEA Experiment HCB bottles (HCB-3); data for HCB and methane. 
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Figure 4.60b  Results for one of the TEA Experiment HCB bottles (HCB-3); data for PeCB, 1,2,4,5-TeCB, and 1,2,4-TCB. 
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Figure 4.61a  Results for the chlorinated benzenes autoclaved controls (average of triplicates); HCB only.  Error bars 
represent ± one standard deviation. 
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Figure 4.61b  Results for the chlorinated benzenes autoclaved controls (average of triplicates); PeCB and 1,2,4,5-TeCB.  
Error bars represent ± one standard deviation. 
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Figure 4.62  Results for one of the TEA Experiment PeCB bottles (PeCB-1). 
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Figure 4.63  Results for one of the TEA Experiment PeCB bottles (PeCB-2). 
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Figure 4.64  Results for one of the TEA Experiment PeCB bottles (PeCB-3). 
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Figure 4.65  Results for one of the TEA Experiment 1,2,4,5-TeCB bottles (1,2,4,5-TeCB-1). 
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Figure 4.66  Results for one of the TEA Experiment 1,2,4,5-TeCB bottles (1,2,4,5-TeCB-2). 
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Figure 4.67  Results for one of the TEA Experiment 1,2,4,5-TeCB bottles (1,2,4,5-TeCB-3). 
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Figure 4.68  Results for one of the TEA Experiment 1,2,4-TCB bottles (1,2,4-TCB-1). 
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Figure 4.69  Results for one of the TEA Experiment 1,2,4-TCB bottles (1,2,4-TCB-2). 
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Figure 4.70  Results for one of the TEA Experiment 1,2,4-TCB bottles (1,2,4-TCB-3). 
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Figure 4.71  Results for one of the TEA Experiment 1,2-DCB bottles (1,2-DCB-1). 
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Figure 4.72  Results for one of the TEA Experiment 1,2-DCB bottles (1,2-DCB-2). 
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Figure 4.73  Results for one of the TEA Experiment 1,2-DCB bottles (1,2-DCB-3). 
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Figure 4.74  Results for one of the TEA Experiment 1,3-DCB bottles (1,3-DCB-1). 
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Figure 4.75  Results for one of the TEA Experiment 1,3-DCB bottles (1,3-DCB-2). 
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Figure 4.76  Results for one of the TEA Experiment 1,3-DCB bottles (1,3-DCB-3). 
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Figure 4.77  Results for one of the TEA Experiment 1,4-DCB bottles (1,4-DCB-1). 
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Figure 4.78  Results for one of the TEA Experiment 1,4-DCB bottles (1,4-DCB-2). 
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Figure 4.79  Results for one of the TEA Experiment 1,4-DCB bottles (1,4-DCB-3). 
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Figure 4.80  Results for one of the TEA Experiment CB bottles (CB-1). 
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Figure 4.81  Results for one of the TEA Experiment CB bottles (CB-2). 
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Figure 4.82  Results for one of the TEA Experiment CB bottles (CB-3). 
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Figure 4.83  Results for the first set of TEA Experiment chlorinated benzenes WCs (average of triplicates).  Error bars 
represent ± one standard deviation. 
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Figure 4.84  Results for the second set of TEA Experiment chlorinated benzenes WCs (average of triplicates).  Error bars 
represent ± one standard deviation. 
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Figure 4.85  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 1 TCE only bottles (TCE only-1). 
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Figure 4.86  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 1 TCE only bottles (TCE only-2). 
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Figure 4.87  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 1 TCE only bottles (TCE only-3). 
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Figure 4.88  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 1 TCE + 1,1,1-TCA bottles (TCE + 1,1,1-TCA-
1). 
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Figure 4.89  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 1 TCE + 1,1,1-TCA bottles (TCE + 1,1,1-TCA-
2). 
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Figure 4.90  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 1 TCE + 1,1,1-TCA bottles (TCE + 1,1,1-TCA-
3). 
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Figure 4.91  Comparison of the effect of 300 µM 1,1,1-TCA on reductive dechlorination of TCE (averages of 
triplicates).  Error bars represent ± one standard deviation. 
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Figure 4.92  Comparison of the effect of 300 µM 1,1,1-TCA on reductive dechlorination of cDCE (averages of 
triplicates).  Error bars represent ± one standard deviation. 
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Figure 4.93  Comparison of the effect of 300 µM 1,1,1-TCA on reductive dechlorination of VC (averages of 
triplicates).  Error bars represent ± one standard deviation. 
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Figure 4.94  Comparison of the effect of 300 µM 1,1,1-TCA on production of ethene (averages of triplicates).  Error 
bars represent ± one standard deviation. 
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Figure 4.95  Comparison of the effect of 300 µM 1,1,1-TCA on production of methane (averages of triplicates).  Error 
bars represent ± one standard deviation. 
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Figure 4.96  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 TCE only bottles (TCE only-1). 
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Figure 4.97  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 TCE only bottles (TCE only-2). 
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Figure 4.98  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 TCE only bottles (TCE only-3). 
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Figure 4.99  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 31 µM TCE + 0.7 µM 1,1,1-TCA bottles (31 
µM TCE + 0.7 µM 1,1,1-TCA-1). 
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Figure 4.100  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 31 µM TCE + 0.7 µM 1,1,1-TCA bottles 
(31 µM TCE + 0.7 µM 1,1,1-TCA-2). 
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Figure 4.101  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 31 µM TCE + 0.7 µM 1,1,1-TCA bottles 
(31 µM TCE + 0.7 µM 1,1,1-TCA-3). 
  
206 
0.0
0.5
1.0
1.5
2.0
2.5
0 5 10 15 20 25 30 35 40 45
Time (days)
T
C
E
,
 
1
,
1
,
1
-
T
C
A
,
 
c
D
C
E
,
 
V
C
,
 
a
n
d
 
E
t
h
e
n
e
 
(
µ
µ µ
µ
m
o
l
/
b
o
t
t
l
e
)
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
M
e
t
h
a
n
e
 
(
µ
µ µ
µ
m
o
l
/
b
o
t
t
l
e
)
TCE 1,1,1-TCA cDCE VC Ethene Methane Lactate Addition
 
 
Figure 4.102  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 31 µM TCE + 3.6 µM 1,1,1-TCA bottles 
(31 µM TCE + 3.6 µM 1,1,1-TCA-1). 
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Figure 4.103  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 31 µM TCE + 3.6 µM 1,1,1-TCA bottles 
(31 µM TCE + 3.6 µM 1,1,1-TCA-2). 
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Figure 4.104  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 31 µM TCE + 3.6 µM 1,1,1-TCA bottles 
(31 µM TCE + 3.6 µM 1,1,1-TCA-3). 
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Figure 4.105  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 31 µM TCE + 18 µM 1,1,1-TCA bottles 
(31 µM TCE + 18 µM 1,1,1-TCA-1). 
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Figure 4.106  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 31 µM TCE + 18 µM 1,1,1-TCA bottles 
(31 µM TCE + 18 µM 1,1,1-TCA-2). 
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Figure 4.107  Results for one of the 1,1,1-TCA Inhibition Experiment Phase 2 31 µM TCE + 18 µM 1,1,1-TCA bottles 
(31 µM TCE + 18 µM 1,1,1-TCA-3). 
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Figure 4.108  Comparison of the effect of 1,1,1-TCA on reductive dechlorination of TCE at all levels (averages of 
triplicates). 
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Figure 4.109  Comparison of the effect of 1,1,1-TCA on reductive dechlorination of cDCE at all levels (averages of 
triplicates). 
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Figure 4.110  Comparison of the effect of 1,1,1-TCA on reductive dechlorination of VC at all levels (averages of 
triplicates). 
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Figure 4.111  Comparison of the effect of 1,1,1-TCA on production of ethene at all levels (averages of triplicates). 
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Figure 4.112  Comparison of the effect of 1,1,1-TCA on production of methane at all levels (averages of triplicates). 
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Figure 4.113  Results for the 1,1,1-TCA Inhibition Experiment Phase 2 WCs (average of triplicates).  Error bars represent 
± one standard deviation. 
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Figure 4.114  Results for one of the lactate only-amended bottles (lactate only-1). 
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Figure 4.115  Results for one of the lactate only-amended bottles (lactate only-2). 
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Figure 4.116  Results for one of the lactate only-amended bottles (lactate only-3). 
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Figure 4.117  Results for one of the lactate + bioaugmentation-amended bottles (bio + lactate-1). 
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Figure 4.118  Results for one of the lactate + bioaugmentation-amended bottles (bio + lactate-2). 
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Figure 4.119  Results for one of the lactate + bioaugmentation-amended bottles (bio + lactate-3). 
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Figure 4.120  Results for one of the EOS® 450 + bioaugmentation-amended bottles (bio + EOS® 450-1). 
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Figure 4.121  Results for one of the EOS® 450 + bioaugmentation-amended bottles (bio + EOS® 450-2). 
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Figure 4.122  Results for one of the EOS® 450 + bioaugmentation-amended bottles (bio + EOS® 450-3). 
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Figure 4.123  Results for one of the EOS® 598 + bioaugmentation-amended bottles (bio + EOS® 598-1). 
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Figure 4.124  Results for one of the EOS® 598 + bioaugmentation-amended bottles (bio + EOS® 598-2). 
  
229 
0
5
10
15
20
25
30
0 10 20 30 40 50 60 70 80 90
Time (days)
P
C
E
,
 
T
C
E
,
 
c
D
C
E
,
 
V
C
,
 
E
t
h
e
n
e
,
 
a
n
d
 
M
e
t
h
a
n
e
 
(
µ
µ µ
µ
m
o
l
/
b
o
t
t
l
e
)
PCE TCE cDCE VC Ethene Methane Bioaugmentation
 
 
 
Figure 4.125  Results for one of the EOS® 598 + bioaugmentation-amended bottles (bio + EOS® 598-3). 
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Figure 4.126  Results for one of the EOS® 598B42 + bioaugmentation-amended bottles (bio + EOS® 598B42-1). 
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Figure 4.127  Results for one of the EOS® 598B42 + bioaugmentation-amended bottles (bio + EOS® 598B42-2). 
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Figure 4.128  Results for one of the EOS® 598B42 + bioaugmentation-amended bottles (bio + EOS® 598B42-3). 
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Figure 4.129  Results for one of the EOS® 598B42 + EOS® Vitamin B12 solution + bioaugmentation-amended bottles (bio 
+ EOS® 598B42 + B12-1). 
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Figure 4.130  Results for one of the EOS® 598B42 + EOS® Vitamin B12 solution + bioaugmentation-amended bottles (bio 
+ EOS® 598B42 + B12-2). 
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Figure 4.131  Results for one of the EOS® 598B42 + EOS® Vitamin B12 solution + bioaugmentation-amended bottles (bio 
+ EOS® 598B42 + B12-3). 
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Figure 4.132  Comparison of lactate and EOS® as electron donors on PCE reductive dechlorination (averages of 
triplicates). 
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Figure 4.133  Comparison of lactate and EOS® as electron donors on TCE reductive dechlorination (averages of 
triplicates). 
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Figure 4.134  Comparison of lactate and EOS® as electron donors on cDCE reductive dechlorination (averages of 
triplicates). 
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Figure 4.135  Comparison of lactate and EOS® as electron donors on VC reductive dechlorination (averages of 
triplicates). 
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Figure 4.136  Comparison of lactate and EOS® as electron donors on ethene production (averages of triplicates). 
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Figure 4.137  Results for one of the unexposed oxygen tolerance bottles (no exposure-1). 
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Figure 4.138  Results for one of the unexposed oxygen tolerance bottles (no exposure-2). 
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Figure 4.139  Results for one of the unexposed oxygen tolerance bottles (no exposure-3). 
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Figure 4.140  Results for one of the 24-hour exposed oxygen tolerance bottles (24 hr exposure-1). 
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Figure 4.141  Results for one of the 24-hour exposed oxygen tolerance bottles (24 hr exposure-2). 
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Figure 4.142  Results for one of the 24-hour exposed oxygen tolerance bottles (24 hr exposure-3). 
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Figure 4.143  Results for percent oxygen in headspace of 24-hour exposed bottles in oxygen tolerance experiment. 
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Figure 4.144  Results for one of the pH 7.0±0.25 bottles (pH 7.0±0.25-1).  Bottle was broken and discarded on day 48, 
therefore, no data is shown after day 48. 
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Figure 4.145  Results for one of the pH 7.0±0.25 bottles (pH 7.0±0.25-2). 
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Figure 4.146  Results for one of the pH 7.0±0.25 bottles (pH 7.0±0.25-3). 
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Figure 4.147  Results for pH adjustment of the pH 7.0±0.25 bottles. 
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Figure 4.148  Results for one of the pH 7.0 with no pH adjustment bottles (pH 7.0 no adjustment-1). 
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Figure 4.149  Results for one of the pH 7.0 with no pH adjustment bottles (pH 7.0 no adjustment-2). 
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Figure 4.150  Results for one of the pH 7.0 with no pH adjustment bottles (pH 7.0 no adjustment-3). 
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Figure 4.151  Results for pH adjustment of the pH 7.0 with no pH adjustment bottles. 
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Figure 4.152  Results for one of the pH 6.5±0.25 bottles (pH 6.5±0.25-1). 
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Figure 4.153  Results for one of the pH 6.5±0.25 bottles (pH 6.5±0.25-2). 
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Figure 4.154  Results for one of the pH 6.5±0.25 bottles (pH 6.5±0.25-3). 
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Figure 4.155  Results for pH adjustment of the pH 6.5±0.25 bottles. 
  
260 
0
5
10
15
20
25
30
35
0 10 20 30 40 50 60 70 80
Time (days)
P
C
E
,
 
T
C
E
,
 
c
D
C
E
,
 
V
C
,
 
E
t
h
e
n
e
,
 
a
n
d
 
M
e
t
h
a
n
e
 
(
µ
µ µ
µ
m
o
l
/
b
o
t
t
l
e
)
PCE TCE cDCE VC Ethene Methane lactate addition
 
 
Figure 4.156  Results for one of the pH 6.0±0.25 bottles (pH 6.0±0.25-1). 
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Figure 4.157  Results for one of the pH 6.0±0.25 bottles (pH 6.0±0.25-2). 
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Figure 4.158  Results for one of the pH 6.0±0.25 bottles (pH 6.0±0.25-3). 
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Figure 4.159  Results for pH adjustment of the pH 6.0±0.25 bottles. 
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Figure 4.160  Results for one of the pH 5.5±0.25 bottles (pH 5.5±0.25-1).  Bottle was broken and discarded on day 48, 
therefore, no data is shown after day 48. 
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Figure 4.161  Results for one of the pH 5.5±0.25 bottles (pH 5.5±0.25-2). 
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Figure 4.162  Results for one of the pH 5.5±0.25 bottles (pH 5.5±0.25-3). 
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Figure 4.163  Results for pH adjustment of the pH 5.5±0.25 bottles. 
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Figure 4.164  Results for one of the pH 8.5±0.25 bottles (pH 8.5±0.25-1). 
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Figure 4.165  Results for one of the pH 8.5±0.25 bottles (pH 8.5±0.25-2). 
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Figure 4.166  Results for one of the pH 8.5±0.25 bottles (pH 8.5±0.25-3). 
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Figure 4.167  Results for pH adjustment of the pH 8.5±0.25 bottles. 
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Figure 4.168  Comparison of pH effect on PCE consumption based on the first PCE and TCE addition at all pH levels 
(averages of triplicates).  Error bars represent ± one standard deviation. 
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Figure 4.169  Comparison of pH effect on TCE consumption based on the first PCE and TCE addition at all pH levels 
(averages of triplicates).  Error bars represent ± one standard deviation. 
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Figure 4.170  Comparison of pH effect on cDCE dechlorination based on the first PCE and TCE addition at all pH levels 
(averages of triplicates).  Error bars represent ± one standard deviation. 
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Figure 4.171  Comparison of pH effect on VC dechlorination based on the first PCE and TCE addition at all pH levels 
(averages of triplicates).  Error bars represent ± one standard deviation. 
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Figure 4.172  Comparison of pH effect on ethene production based on the first PCE and TCE addition at all pH levels 
(averages of triplicates).  Error bars represent ± one standard deviation. 
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Figure 5.1  Reported pathways for reductive dechlorination of chlorinated benzenes.  Pathway reported for SRS enrichment 
culture is indicated by black arrows.  Pathways reported in literature are denoted by colored arrows:  green = ref (28), blue = 
ref (19), pink = ref (49), and orange = ref (5). 
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 Figure A.1  PCE concentration in the P-Area chlorinated ethene plume. 
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Figure A.2  TCE concentration in the P-Area chlorinated ethene plume. 
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Appendix B 
Minimal Media Preparation 
 
Reagents and stock solutions needed for media: 
 
- Phosphate buffer 
In a 100 mL volumetric flask add 5.25 g K2HPO4.  Fill to 100 mL with DDI 
water. 
 
- Salt solution 
In a 100 mL volumetric flask add: 
 5.35 g NH4Cl 
 0.46976 g CaCl2·2H2O 
 0.17787 g FeCl2·H2O 
Fill to 100 mL with DDI water. 
 
- Trace metals solution 
In a 100 mL volumetric flask add: 
 0.03 g H3BO3 
 0.0211 g ZnSO4·7H2O 
 0.075 g NiCl2·6H2O 
 0.1 g MnCl2·4H2O 
 0.01 g CuCl2·2H2O 
 0.15 g CoCl2·6H2O 
 0.002 g Na2SeO3 
 0.01 g Al2(SO4)3·16H2O  
 1 mL concentrated HCl.   
Fill to 100 mL with DDI water. 
 
- Magnesium sulfate solution 
In a 100 mL volumetric flask add 6.25 g MgSO4·7H2O.  Fill to 100 mL with DDI 
water. 
 
- Bicarbonate solution 
In a 500 mL volumetric flask add 8.0 g NaHCO3.  Fill to 500 mL with DDI water. 
 
- Redox solution 
In a 10 mL volumetric flask add 0.01 g resazurin.  Fill to 10 mL with DDI water. 
 
- Yeast extract solution 
In a 100 mL volumetric flask add 0.5 g yeast extract.  Fill to 100 mL with DDI 
water. 
 282 
 
- Ferrous sulfide 
For 1 L of media, weigh into separate glass vials: 
 0.24 g of Na2S·9H2O  
 0.1448 g FeCl2·H2O 
 
Media Preparation 
 
1)  In a 1 L bottle add: 
  10 mL phosphate solution 
  10 mL salt solution 
  2 mL trace metals solution 
  2 mL magnesium sulfate solution 
  1 mL redox solution 
  905 mL DDI water 
 
2)  Autoclave the above solution and allow to cool. 
 
3)  Add: 
  50 mL filter sterilized bicarbonate solution 
  10 mL filter sterilized yeast extract 
 
4)  Transfer the bottle to the glove box along with the vials of sodium sulfide and ferrous 
chloride and 10 mL of sterile DDI water.  When the O2 reaches zero, add the 0.24 g 
of Na2S·9H2O and rinse the vial with ~5 mL of sterile DDI water.  Wait until the 
media turns from pink to clear.   
 
5)  Then add the 0.1448g FeCl2·H2O.  Rinse the vial with ~5 mL of sterile DDI water.   
 
6)  After dispensing the media, remove bottles from the glove box and purge the 
headspace with oxygen-free gas containing 70%N2 and 30%CO2.  This will lower the 
media pH to approximately 7. 
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Appendix C 
Canister and Maintenance Diagram 
 
 
 
Figure C.1  Photo of canister #1 modified with valves and Mininert® sampling port. 
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Figure C.2  Diagram of canister maintenance process for wasting liquid and adding 
media. 
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Figure C.3  Leak test for canister #1 (PCE + TCE + DDI water). 
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Figure C.4  Leak test for canister #2 (PCE + TCE + DDI water). 
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Appendix D 
Results for Acetone Effect on Reductive Dechlorination of PCE and TCE 
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Figure D.1  Results for one of the bottles testing the effect of acetone on PCE and TCE 
dechlorination (PCE+TCE only-1). 
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Figure D.2  Results for one of the bottles testing the effect of acetone on PCE and TCE 
dechlorination (PCE+TCE only-2). 
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Figure D.3  Results for one of the bottles testing the effect of acetone on PCE and TCE 
dechlorination (PCE+TCE only-3). 
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Figure D.4  Results for one of the bottles testing the effect of acetone on PCE and TCE 
dechlorination (PCE+TCE+acetone-1). 
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Figure D.5  Results for one of the bottles testing the effect of acetone on PCE and TCE 
dechlorination (PCE+TCE+acetone-2). 
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Figure D.6  Results for one of the bottles testing the effect of acetone on PCE and TCE 
dechlorination (PCE+TCE+acetone-3). 
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Appendix E 
Results for Phase 1 of Oxygen Tolerance Experiment 
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Figure E.1  Results for the single bottle not exposed to air in Phase 1 oxygen tolerance 
experiment. 
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Figure E.2  Results for the single bottle exposed to air for 12 hours in Phase 1 of oxygen 
tolerance experiment. 
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Figure E.3  Results for the single bottle exposed to air for 24 hours in Phase 1 of oxygen 
tolerance experiment.
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Appendix F 
GC RFs for Halogenated Alkenes and Alkanes in Serum Bottles 
 
Table F.1  GC response factors for chlorinated ethenes, halogenated ethanes, ethene, ethane, and methane. 
 
GC RT Response Factor Conversion Factora Min. Detection Limit Compound 
(min) (µmol/bottle/PAU) R2 (µmol/bottle) (µmol/bottle to mg/L) (µmol/bottle) 
Methane 0.49 1.8837E-06 0.99810 0.0140 0.0002 3.97E-03 
Ethene 0.70 1.0873E-06 0.99999 1.8713 0.0524 5.60E-04 
Ethane 0.90 9.9400E-07 0.99998 0.8984 0.02700 4.17E-04 
VC 2.60 2.3983E-06 0.99991 6.2345 0.3897 2.54E-04 
1,1-DCE 6.00 2.4717E-06 0.99973 6.3184 0.6129 2.99E-04 
tDCE 6.84 6.6197E-06 0.99977 8.2832 0.8035 9.93E-04 
cDCE 6.84 1.1510E-05 0.99922 9.2198 0.8943 5.56E-03 
TCE 10.02 5.6814E-06 1.00000 8.2692 1.0866 8.64E-04 
PCE 14.64 3.8933E-06 0.99958 7.2111 1.1958 6.42E-04 
CA 3.90 4.4833E-06 0.99917 7.9490 0.5128 5.07E-04 
VB 4.90 4.0797E-06 0.99985 7.6824 0.8216 1.03E-02 
Bromoethane 5.60 6.9476E-06 0.99983 8.4621 0.9221 1.61E-03 
1,1-DCA 6.60 1.0539E-05 0.99979 8.9045 0.8812 3.13E-01 
1,2-DCA 8.10 4.0967E-05 0.99986 9.6856 0.9585 2.37E-02 
1,1,1-TCA 8.30 4.6400E-06 0.99975 7.2557 0.9680 4.02E-02 
EDB 12.10 9.6590E-05 0.99944 9.8515 1.8422 1.97E-02 
a Based on liquid volume of 100 mL, gas volume of 60 mL, and 23°C.  
 293 
 
y = 1.8837E-06x
R2 = 9.9810E-01
0
5
10
15
20
25
30
35
40
45
0 5,000,000 10,000,000 15,000,000 20,000,000 25,000,000
PA
M
et
ha
n
e 
( µµ µµm
o
l/b
o
ttl
e)
Figure F.1  GC response curve for methane. 
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Figure F.2  GC response curve for ethene. 
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Figure F.3  GC response curve for ethane. 
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Figure F.4  GC response curve for VC. 
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Figure F.5  GC response curve for 1,1-DCE. 
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Figure F.6  GC response curve for tDCE. 
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Figure F.7  GC response curve for cDCE. 
y = 5.6814E-06x
R2 = 1.0000E+00
0
10
20
30
40
50
60
70
0 3,000,000 6,000,000 9,000,000 12,000,000
PA
TC
E 
( µµ µµm
o
l/b
o
tt
le
)
Figure F.8  GC response curve for TCE. 
 297 
 
y = 3.8933E-06x
R2 = 9.9958E-01
0
10
20
30
40
50
60
0 4,000,000 8,000,000 12,000,000 16,000,000
PA
PC
E 
( µµ µµm
o
l/b
o
ttl
e)
Figure F.9  GC response curve for PCE. 
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Figure F.10  GC response curve for CA. 
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Figure F 11  GC response curve for VB. 
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Figure F 12  GC response curve for bromoethane. 
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Figure F.13  GC response curve for 1,1-DCA. 
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Figure F.14  GC response curve for 1,2-DCA. 
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Figure F.15  GC response curve for 1,1,1-TCA. 
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Figure F.16  GC response curve for EDB.
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Appendix G 
GC RFs for Microcosms 
 
Table G.1  GC response factors for chlorinated ethenes, ethene, and methane used for microcosm evaluation of EOS®. 
 
GC RT Response Factor Conversion Factora Min. Detection Limit Compound (min) (µmol/bottle/PAU) R2 (µmol/bottle to µM) (µmol/bottle to mg/L) (µmol/bottle) 
Methane 0.49 3.1800E-06 0.99770 0.0085 0.0001 3.05E-01 
Ethene 0.70 1.7253E-06 0.99766 1.3042 0.0365 4.72E-03 
VC 2.60 2.6963E-06 0.99700 6.6821 0.4176 4.31E-04 
cDCE 6.84 7.4977E-06 0.99989 15.6339 1.5165 1.23E-03 
TCE 10.02 4.4295E-06 0.99927 11.8295 1.5544 1.39E-03 
PCE 14.64 3.7375E-06 0.99694 8.7862 1.4571 6.09E-04 
a Based on liquid volume of 50 mL, gas volume of 99 mL, and 23°C.  
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Figure G.1  GC response curve for methane in microcosms. 
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Figure G.2  GC response curve for ethene in microcosms. 
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Figure G.3  GC response curve for VC in microcosms. 
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Figure G.4  GC response curve for cDCE in microcosms. 
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Figure G.5  GC response curve for TCE in microcosms. 
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Figure G.6  GC response curve for PCE in microcosms.
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Appendix H 
GC RFs for Canisters 
 
Table H.1  GC response factors for chlorinated ethenes, ethene, and methane used for canisters. 
 
GC RT Adjusted Response Factor Conversion Factorb Min. Detection Limit Compounda 
(min) (µmol/bottle/PAU) R2 (µmol/bottle to µM) (µmol/bottle to mg/L) (µmol/bottle) 
Methane 0.49 7.7095E-05 0.99910 0.0005 0.0000083 7.47E+01 
Ethene 0.70 7.4840E-05 0.99999 0.0338 0.0009 3.33E+02 
VC 2.60 3.1674E-04 0.99971 0.0222 0.0007 2.01E-01 
cDCE 6.84 2.3456E-03 0.99994 0.0510 0.0032 5.56E+00 
TCE 10.02 9.1960E-04 0.99630 0.0549 0.0053 1.32E-01 
PCE 14.64 5.7632E-04 0.99978 0.0539 0.0071 1.03E-01 
 a
 Gas standards (VC, ethene, and methane) were prepared in 160 mL serum bottles and liquid standards (cDCE, TCE, and
 PCE) were prepared in 70 mL serum bottles. 
 
b
 Based on liquid volume of 18 L, gas volume of 1.6 L, and 23°C. 
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Figure H.1  GC response curve for methane in canisters. 
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Figure H.2  GC response curve for ethene in canisters. 
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Figure H.3  GC response curve for VC in canisters. 
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Figure H.4  GC response curve for cDCE in canisters. 
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Figure H.5  GC response curve for TCE in canisters. 
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Figure H.6  GC response curve for PCE in canisters. 
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Appendix I 
GC RFs for Chlorinated Benzenes 
 
Table I.1  GC response factors for chlorinated benzenes. 
 
GC RT Response Factor Conversion Factora Min. Detection Limit Compounda 
(min) (µmol/bottle/PAU) R2 (µmol/bottle to µM) (µmol/bottle to mg/L) (µmol/bottle) 
CB 2.0 7.4729E-06 0.99953 9.1734 1.0326 5.27E+00 
1,2-DCB 3.9 2.4425E-05 0.99852 9.5584 1.4051 2.68E+00 
1,3-DCB 3.4 1.9570E-05 0.99955 9.2809 1.3643 4.93E+00 
1,4-DCB 3.5 1.8357E-05 0.99984 9.3138 1.3691 5.28E-02 
1,2,4-TCB 7.4 3.5488E-05 0.99543 9.5441 1.7318 5.55E-02 
1,3,5-TCB 4.6b 2.9804E-07 0.99791 9.5547 1.7337 4.01E-01 
1,2,4,5-TeCB 6.3b 5.0256E-07 0.99831 9.7566 2.1063 2.81E-02 
PeCB 9.1b 1.6270E-07 0.99284 9.8260 2.4596 1.24E-04 
HCB 13.9b 5.6164E-08 0.99662 9.7468 2.7755 1.48E-05 
 a
 Based on liquid volume of 100 mL, gas volume of 60 mL, and 23°C. 
 b
 Retention times using ECD; otherwise, retention times are based on FID analysis. 
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Figure I.1  GC response curve for CB. 
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Figure I.2  GC response curve for 1,2-DCB. 
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Figure I.3  GC response curve for 1,3-DCB. 
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Figure I.4  GC response curve for 1,4-DCB. 
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Figure I.5  GC response curve for 1,2,4-TCB. 
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Figure I.6  GC response curve for 1,3,5-TCB. 
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Figure I.7  GC response curve for 1,2,4,5-TeCB. 
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Figure I.8  GC response curve for PeCB. 
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Figure I.9  GC response curve for HCB. 
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